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The actin cytoskeleton plays a central role in endocytosis in Saccharomyces 
cerevisiae. Sla2p is an interesting adaptor molecule that is involved in both these 
processes and is a vital link between them. Deletion of this protein causes massive 
accumulation of actin at the cortex as well as a complete block in endocytosis. Sla2p 
negatively regulates actin polymerization by inhibiting Pan1p, an activator of the 
Arp2/3 nucleator. However, the regulation of this process is poorly understood. 
 In this study I show that Sla2p is subjected to phosphorylation by Prk1p and 
possibly Ark1p kinase. These kinases constitute a unique family of actin regulating 
kinase whose substrates include many components of actin machinery as well as 
endocytic and membrane trafficking pathways. The phosphorylation on Sla2p exerts 
subtle regulatory effects leading to longer lifespan at the cortex and endocytic defects 
and also changes Sla2p’s affinity for Scd5p and Pan1p. I also show that Sla2p can be 
dephosphorylated by the Scd5p/Glc7p complex, in a manner similar to what is 
reported for Pan1p. I postulate that this regulatory cycle is important for function of 
Sla2p in endocytosis and actin organization. 
 Secondly, I studied the C-terminal portion of Sla2p, which contains two 
additional coiled-coil domains along with an F-actin binding THATCH domain. I 
found that the C-terminal region of Sla2p is important for binding Ark1p and Scd5p, 
while the second coiled-coil domain starting from 700 till 730 amino acids is 
necessary for both these interactions. Deletion of this short domain causes severe 
temperature sensitivity, actin aberrations and a complete block in endocytosis. I also 
made a series of truncations in the C-terminal region of Sla2p and studied the effects 
of such mutations. Different truncations gave different phenotypes while the strongest 
phenotype was obtained by deleting just the 30 amino acids constituting the coiled-
vii 
coil domain (sla2CC mutant). I hypothesize that this particular allele is toxic 
because the 30 amino acids contains a part of the upstream helical domain that 
regulates binding to F-actin.  
 Thirdly, I performed a high-copy suppressor screening and found that over 
expressing Abp1p can rescue the temperature sensitivity of sla2CC. In addition to 
growth, overexpressing Abp1p can also rescue actin aberrations such as actin clumps 
and bars seen in the mutant. Receptor-mediated and fluid-phase endocytosis are also 
significantly improved in cells containing high-copy number plasmid with ABP1 but 
not in mutant cells containing empty plasmid. No deleterious effects were observed 
upon overexpression of Abp1p in wild-type cells.  
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1. INTRODUCTION 
The world record in weightlifting, the flick of the wrist as it turns a page, the budding 
of a minute yeast cell, are processes all made possible by a polymer of 7 nanometers 
known as actin filaments. These filaments drive such vital functions such as muscle 
contraction, cell division and maintenance of basic cell shape. Evolution created a 
structural system so effective that it has been conserved all the way from the 
unicellular, free-dwelling yeast cells to us human beings- organisms of unimaginable 
complexity and functions.   
 
1.1Actin cytoskeleton 
Actin is globular 42-kDa protein ubiquitously expressed in all eukaryotic cells. It 
exists in 2 forms in the cell:  as a monomer (globular) or as a filamentous polymer. 
Polymerization of the monomer into filaments involves a nucleation step and is 
carried out by specialized actin nucleators in the cell. The actin cables have very 
important functions in vital cellular functions such as inducing movement, preserving 
cell shape, maintaining integrity of cellular junctions, carrying out endocytosis and 
exocytosis, enabling polarization and a many other important functions. This ancient 
system has been well conserved in all eukaryotic cells observed. In this section, I look 
closer into the actin network found in S. cerevisiae and its regulation and function. I 
also draw parallels with the mammalian actin cytoskeleton, and examine the 
similarities and dissimilarities. 






1.1.1 Actin cytoskeleton in yeast 
Actin cytoskeleton in yeast has been studied intensely over the past two decades. In 
1984 two seminal papers by Adams, Kilmartin and Pringle described that the actin in 
yeast manifested in three primary structures: actin patches at cell cortex, actin cables 
running along the long axis of the cell, and the acto-myosin ring at the bud neck 
(Moseley and Goode, 2006). Since then, the interest in yeast cytoskeleton has 
scarcely abated. Subsequent studies showed that the distribution of these various actin 
structures is 
Figure 1.1 Schematic of actin polymerization 
Actin monomers bind to profilin and are attached to the barbed end of the growing actin filament. Actin 
has very weak ATPase activity, which slowly converts its bound ATP to ADP as the filament matures. 
The older “ADP end” is called pointed end that usually is the end that depolymerizes. On the left is the 
crystal structure of actin bound to profilin. (Reproduced with permission from publisher from Moseley 
and Goode, 2006, Microbiology and Molecular Biology Reviews, Volume 70, Issue 3.) 
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cell-cycle dependent and that it plays a major role in various cell-cycle events. Actin 
patches were found concentrated at sites of polarized growth- marking the emergence 
of the nascent bud. In larger budded or unbudded cells, the patches are evenly 
distributed all over the cortex. Just before cytokinesis, the actomyosin ring, which is 
thought to facilitate the pinching off of the bud from the mother cell, is assembled at 
the bud neck (Amberg, 1998).  
 Cortical actin patches, are of particular interest as they associate with a variety 
of proteins involved in various aspects of cellular functions such as endocytosis, 
exocytosis, cell wall morphogenesis, polarity, etc. Live-cell imaging data revealed 
that these structures are immensely motile and assemble-dissemble in a very precise 
temporally controlled manner with rates ranging from 0.1-0.5 mm/s. All the proteins 
associated with the patches also appear and disappear from the cortex in a tightly 
controlled sequence. This sequence correlates to various aspects of the early 
endocytic steps. Many different approaches have confirmed that actin cortical patches 
in yeast are indeed the sites of endocytosis (Huckaba et al, 2004, Kaksonen et al, 
Figure1.2 Yeast actin cytoskeleton 
through the cell cycle 
The organization of the yeast actin 
cytoskeleton changes with the cell cycle. 
The actin patches gathering at the 
presumptive bud site mark the initiation 
of budding. As the bug grows, actin 
patches preferentially localized at the 
small bud and few are seen in the mother 
cell. Actin cables run along the mother-
bud axis. As the bud reaches it optimal 
size, patches are equally distributed 
between mother and bud and the cables 
appear less organized. The cytokinetic 
acto-myosin ring at the bud neck is 
formed as the cell undergoes division to 
give a mother and daughter cell. 
(Reproduced with permission from 
Amberg D.C, 1998, Molecular Biology 
of the Cell, Volume 9)  
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2005). The next few sections describe the components and characteristics of the 
various actin structures. 
1.1.2 Assembly of actin at cortical patches 
Actin patches are known to contain short, highly branched filaments of actin. The 
formation of these actin patches is credited to the actin-polymerization activity of 
actin nucleators. The single most important nucleator in the context of the actin patch 
is the Arp2/3 complex, which localizes to the patch and is the sole nucleator 
implicated in their formation (Moreau et al 1996, Winter et al 1997 and 1999). Other 
actin-nucleators such as the formins - Bni1p and Bnr1p- play a very minor role in 
patches. The activity of the Arp2/3 complex is activated only in the presence of 
certain proteins known as nucleation-promoting factors (NPF). These factors play a 
very important regulatory role in actin patch formation and movement. The various 
components, regulators and mechanisms of this complex structure are discussed in 
detail in the sections following. 
 1.1.2.1 Arp2/3 complex 
This complex consists of seven conserved subunits: 2 actin related proteins (Arp2p 
and Arp3p) and five other proteins namely Arc40p, Arc35p, Arc19p, Arc18p and 
Arc15p. The ARP2 gene was the first component to be identified by its homology to 
actin. This is an essential gene and arp2 temperature sensitive mutants are defective 
in endocytosis and actin organization (Moreau et al 1996, Moseley and Goode, 2006). 
Except for Arc18p, all other Arp2/3 complex genes are essential for survival (Winter 
et al 1997 and 1999). Ablation or decrease in protein levels resulted in complete loss 
of cortical actin patches. 
 
 




















 The Arp2p and Arp3p mimic the barbed end of an actin filament and initiate 
nucleation of other actin molecules (Figure 1.3). The complex not only starts actin 
polymerization de novo but also induces branching by attaching to preexisting actin 
filaments. The new daughter filament branches off at a 70
o
 angle to the mother 
filament. By itself, the Arp2/3 complex has very low actin polymerization abilities. 
Nucleation promoting factors NPFs are found to bind to Arp2/3 and bring about a 
conformational change so that the Arp2p and Arp3p (Robinson et al, 2001) subunits 
Figure 1.3 Structure and function of the Arp2/3 complex 
a) Cartoon representation of the Arp2/3 complex and spatial orientation of various subunits 
ARPC1 through 5 are labeled 1-5 in the diagram 
b) Crystal structure of bovine Arp2/3 complex (ribbon diagram) 
c) Predicted model of active conformation of the Arp2/3 complex 
d) Schematic showing the orientation of Arp2/3 complex in relation with an existing actin 
filament. The new filament is aligned at an angle of ~70
o
, to form a Y-shaped branch on the 
existing mother filament 
e) Two existing models on the orientation of the complex with respect to the growing filament. 
Both models propose that both Arp2 (light blue) and Arp3 (yellow) subunits interact with the 
pointed end of the daughter filament 
Reproduced with permission from Goley and Welch, 2006 Nature Reviews Molecular and Cell 
Biology Volume 7, October 2006 
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are brought closer together. These proteins then initiate filament formation (Figure 
1.3) by mimicking an actin dimer (Rodal et al, 2005). The different NPFs found in 
S.cerevisiae are described in greater depth in the section below. 
1.1.2.2 Nucleation promoting factors 
The Arp2/3 complex in yeast is activated by 5 NPFs namely: Las17p, Myo3p, 
Myo5p, Pan1p and Abp1p (Moseley and Goode, 2006). The hallmark feature of an 
NPF is the presence of the acidic domain that facilitates interaction with the complex, 
most likely via Arp3p or ARPC1. All these proteins bind to either F- or G-actin and 
have varying dependence on actin binding for their Arp2/3 activator function. Las17p 
binds to G-actin while Myo3p, Myo5p, Pan1p and Abp1p bind to actin filaments. The 
actin binding ability is necessary for function in the case of Pan1p, Las17p and Abp1p 
but not for the myosins (D’Agostino and Goode, 2005). 
(i) Las17p, also known as Bee1p, was the first NPF discovered in S.cerevisiae and is 
homologous to the mammalian WASP (Wiskott Aldrich Syndrome protein). Deletion 
of this gene causes severe actin patch disorganization. Subsequent studies showed that 
Las17p is required for actin assembly specifically at actin patches. The C-terminal 
portion of Las17p folds into a “WA domain” consisting of the actin binding WH2 
motif and the Arp2/3 binding acidic sequence (Figure 1.4). This domain was found to 
have very potent NPF activity (Moseley and Goode, 2006). 







Interestingly, the full length Las17p displays a much higher NPF than the WA domain 
alone, suggesting that the N-terminal of the protein acted in concert with WA to 
activate Arp2/3 complex. In vivo, Las17p is under stringent regulation by a host of 
proteins (Rodal et al, 2003) and is maintained in an inactive state. Unlike its 
mammalian counterpart N-WASP, Las17p is not directly activated by Rho GTPase 
switch. Instead, the binding of Sla1p and Bbc1p to Las17p significantly decreases its 
NPF function, and hence regulates its activity. Las17p activators include Vrp1p (yeast 
WIP) (Naqvi et al, 1998, Thanabalu et al, 2007), type I myosins, Rvs167p amongst 
Figure 1.4 Domain organizations of various nucleation-promoting factors in yeast 
a) The five NPFs in yeast and their domain structures. The actin binding domains are highlighted in red 
(WH2 is Pan1p and Las17p, ADFH in Abp1p and TH2 in Myo3p and Myo5p) and the Arp2/3 binding 
acidic domain is shaded yellow. 
b) Comparison and alignment of the Arp2/3-binding consensus motifs (acidic motif) from the various 
NPFs  
(Reproduced with permission from publisher from Moseley and Goode, 2006, Microbiology and 
Molecular Biology Reviews, Volume 70, Issue 3.) 
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others. The exact mechanism of Las1p inhibition and release are not clearly 
understood. 
(ii) Pan1p: is an important multi-modular protein, important for endocytosis. Pan1p is 
recruited as an early patch protein, around the same time as Las17p and Sla2p, 
(Kaksonen et al, 2004) which is way before the Arp2/3 complex is recruited to the 
cortex. Pan1p binds to End3p, Sla1p, Sla2p as well as clathrin adaptors, any of which 
could be involved in its recruitment. It is an essential gene in S.cerevisiae but its NPF 
activity is not vital to the cell (Moseley and Goode, 2006). The acidic domain, which 
binds Arp2/3 directly is present in C-terminal of Pan1p and an atypical WH2 domain, 
also in the C-terminal, is responsible for its low affinity to F-actin. Pan1p is thought to 
promote branched actin network, just below the cell membrane. Its NPF activity is 
shown to be negatively regulated by Prk1p phosphorylation (Toshima et al, 2005, 
Zeng et al, 1999) as well as binding with Sla2p (Toshima et al, 2007). Sla2p binds 
Pan1p’s coiled-coil domain and prevents its association with F-actin. Without binding 
to actin filaments, Pan1p is no longer able to activate Arp2/3 complex. It is not 
entirely certain as to how and when Pan1p’s inhibition might be relieved. 
Scd5/End3/Glc7p phosphatase complex is shown to dephosphorylate Pan1p in a 
temporally regulated manner (Zeng et al, 2007) and this provides an important step in 
activating actin polymerization, just as the vesicle is detaching from the plasma 
membrane. How the inhibition by Sla2p is overcome is yet to be determined.  
(iii) Myo3p and Myo5p: are the yeast type-1 myosins, which function both as actin 
independent motor molecules as well as NPFs. These molecules comprise of an N-
terminal motor domain, a lipid-binding TH1 domain, an F-actin binding TH2 domain, 
an SH3 domain and an Arp2/3 binding acidic motif (Moseley and Goode, 2006). 
Genetic studies show a functional redundancy of these type 1 myosins with Las17p. 
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The biochemical properties of type 1 myosin NPF is not determined in S.cerevisiae 
but in S.pombe the TH1-SH3-A fragment shows mild actin binding properties and an 
ability to activate Arp2/3 in vitro. Binding to yeast WIP, Vrp1p, appears to be 
important for Myo3p and Myo5p’s NPF activities (Evangelista et al, 2000, Mochida 
et al, 2002). These molecules also appear to play an important role in the scission step 
of endocytosis. Deletions of both genes causes long invaginations of the plasma 
membrane, which are tipped with the endocytic coat proteins. The type 1 myosins are 
thought to play a role in altering the composition and organization of membrane 
domains, in a yet poorly understood manner. 
(iv) Abp1p: 85kDa protein was first identified as a protein that is precipitated with 
actin filaments, is one of the first actin binding proteins discovered in yeast (Drubin et 
al, 1988). It is tightly associated with actin patches and it is arrives at the endocytic 
complex along with Myo3p and Myo5p and its presence signifies the approach of the 
actin machinery to the endocytic machinery. Upon the onset of the rapid patch 
movement, type I myosins dissociate, but Abp1p remains attached to the vesicle and 
continues on with its downward journey (Kaksonen et al, 2004). Abp1p is a non-
essential gene (Drubin et al, 1988) but abp1 cells fail to dissociate Sla1p and other 
early patch components during this rapid patch movement (Kaksonen et al, 2005). 
Abp1p is therefore thought to play an important role in dissociation of the coat 
complex. It is thought to be able to recruit Prk1p and Ark1p kinases (Haynes et al, 
2007 and Fazi et al, 2002), which plays a role in disrupting protein-protein 
interaction. Abp1p also recruits Sjl1p, the synaptojanin homologue, which is 
implicated in coat disassembly (Stefan et al, 2005).  
Abp1p contains an N-terminal ADF/cofilin homology domain that binds to 
actin, two acidic sequences and a C-terminal SH3 domain. The actin binding activity 
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of Abp1p is strictly required for its NPF activity. Abp1p recruits Arp2/3 complex on 
the sides of mother filaments and induces branching. It has the highest affinity for 
Arp2/3, given its two acidic motifs. However, its NPF activity is weak compared to 
Las17p and Pan1p. It has been postulated that Abp1p acts as a competitive antagonist 
to these two NPFs (D’Agostino and Goode, 2005). Abp1p appears last at the actin 
patch, just before the rapid movement. It might function in dislodging the earlier 
NPFs from the coat and allow for the transition between slow to fast movement of the 
patch. In addition, Abp1p also recruits Srv2/CAP to the patches and induce rapid 
turnover of F-actin, which has been implicated in the slow movement of patches prior 
to inward vesicle movement. 
1.1.3 Components of actin patches and proteins associated 
with them 
Actin patch is highly branched filamentous actin associated with long membrane 
invagination as revealed by electron microscopic analysis of spheroplasted yeast cells 
(Mulholland et al, 1994). These membrane invaginations are thought to be endocytic 
movements in progress. Further EM studies showed that these structures co-labeled 
with antibodies against Abp1 and members of the Arp2/3 complex.  
Many in vivo and EM studies have been performed to show the exact 
formation that actin filaments assume in these patches. Actin cables form a branched 
network with uniform polarity. The Arp2/3 complex, bound to the pointed ends, is 
always oriented towards the apex of the forming vesicle while the barbed end is 
always towards the interior of the cell (Moseley and Goode, 2006). 
Live-cell and fixed cell images have shown that actin patches partially or 
transiently co-localize with several proteins categorized as cortical patch proteins. 
These proteins, when tagged with GFP or when detected by immuno-fluorescence, 
show punctate distribution all over the cell cortex, which is not unlike the actin 
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patches themselves. Upon co-labeling these proteins along with actin patch 
components, many of the cortical protein show partial co-localization with actin 
patches (Kaksonen et al, 2003). These proteins included Sla1p, Sla2p, Pan1p, Scd5p, 
Rvs167p, Vrp1p, Las17p, yAP1801/2p, End3p, Ark1p, Prk1p, Myo3/5p and Sac6p 
amongst many others. Many of these proteins are directly involved in actin 
polymerization and organization (Pan1p, Sac6p, Las17p and Abp1p) while others are 
important players in various steps of endocytosis and subsequent trafficking steps 
(Kaksonen et al, 2005). The functions of these proteins are explained in greater detail 
in subsequent sections. 
1.1.4 Dynamics of actin patches and their associated 
proteins 
Early studies of actin patch revealed them to be highly motile (Waddle et al, 1996) 
with lifetimes of about 10-20 seconds. Patches assembled in sites of polarized growth 
and then began to move away throughout the cortex. Rapid actin assembly and 
turnover power this rapid movement of patches at the cortex. It has been postulated 
that steps in actin-patch maturation correspond to various stages of endocytosis. Each 
distinct step is marked by different speeds and directions of movement and has been 
carefully delineated. Elegant live-cell microscopic analyses by Kaksonen et al (2003) 
established a tight choreography of patch protein assembly and disassembly that 
occurs with very strict spatial and temporal control. The authors have proposed a 
pathway of protein recruitment and how this correlated with various steps in 
endocytosis. Huckaba et al in 2004 showed a colocalization of actin patches with 
FM4-64 labeled endocytic vesicles and also showed the early movement of these 
vesicles from the membrane to the cell interior, along actin cables. These studies 
show that the patches have clearly different stages each corresponding to a different 
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step in the endocytic process. Described below are the various stages in a lifespan of a 
typical actin patch (Figure 1.5). 
(i) Early recruitment/ non-motile phase: The earliest step of endocytosis 
logically begins with receptors such as permeases binding to their cargo/ligand and 
undergoing some sort of post-translational modification (mono-ubiquitination and/or 
phosphorylation). These modifications in turn attract members of the endocytic 
machinery. Alternatively, it has been proposed that pre-formed, pre-endocytic, static 
complexes may already be present at the cell cortex. These structures known as 
eisosomes, recruit and concentrate ligand/cargo-bound receptors (Moseley and 
Goode, 2006). The first group of proteins to be recruited at the presumptive site are 
clathrin and clathrin adaptors i.e. yAP1801/2 (AP180 homologues), Ent1/2p (epsin 
homologues), Ede1p (Eps15R homologue), Scd5p, Sla1p and Sla2p. These proteins, 
in turn, recruit NPFs such as Pan1p, End3p and Las17p, which can initiate actin 
assembly. Recruitment of Rvs167p (amphiphysin) by Sla2p is thought to induce 
membrane curvature, required in order to form the vesicle. This recruitment step lasts 
about 30-40 seconds.  
(ii) Intermediate stage/slow motility phase: This step is thought to coincide 
with membrane invagination, wherein, the coat complex is observed making slow, 
non-directional movement within the plane of the cortex. The actin machinery 
consisting of Abp1p, Myo3p and Myo5p join at this point and initiate short burst of 
actin polymerization that results in the slow movement. 
(iii) Scission/rapid movement phase: All of a sudden, the cortical patch 
embarks on a rapid movement to the interior of the cells. The onset of this movement 
is coincidental with shedding of many of the patch components like Sla2p, Sla1p, 
Las17p, Pan1p and the type I myosins. Membrane scission also occurs at this point, 
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presumably aided by Rvs167p and the type 1 myosins, which are thought to provide a 
sudden burst of actin polymerization, bending the membrane. Once the vesicle has 
left the cortex, it begins rapid, inward movement along actin cables, which guide the 
endocytic vesicles to the early endosomes. The proteins still associated with the 
vesicle at this point are Abp1p, Arp2/3 complex, capping proteins and Sac6p, an actin 
bundling protein (Moseley and Goode, 2006).  
The various steps of the maturation of an actin patch have been delineated by 
visualizing live cells by tagging the various components with fluorescent proteins 
such as GFP or CFP (Kaksonen et al, 2005). This technique allows the researchers to 
appreciate the tight choreography that exits between the various components and how 
they behave either in concert or sequentially to bring about the process of endocytosis 
(Figure 1.5). 
 
Figure 1.5 Endocytic patch maturation 
stages and sequence of coat-protein 
assembly 
This figure shows the sequential assembly 
of coat proteins through the process of 
endocytosis. Early coat proteins such as 
clathrin, Sla1p, End3p, Pan1p and Sla2p 
assemble along with Las17p. Actin 
machinery consisting of filaments, Arp2/3, 
Abp1p and other capping/bundling factors 
are recruited and actin polymerization 
ensues. Late endocytic proteins such as 
Rvs161/7 and myosins initiate scission and 
de-coating occurs as the newly formed 
vesicle begins to move inwards 
Reproduced with permission from 
publisher from Kaksonen et al, 2006 
Nature Reviews Molecular and Cell 
Biology, Volume 7. 
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 1.1.5 Other actin structures in yeast 
Other than actin patches yeast contains two other distinct actin structures namely- 
actin cables and acto-myosin ring 
1.1.5.1 Actin cables 
Yeast cells use actin cables as highways for vesicles to travel on. In contrast, 
mammalian cells use microtubules primarily for vesicular transport. In early G1 cells, 
unbudded cells select a presumptive bud site by getting cortical cues from previous 
cell divisions. Polarity determinants such as the polarity cap also play an important 
role in bud-site selection. These polarity determinants also recruit actin cable 
assembly machinery, which begins to assemble and reorient actin cables at this site. 
Cables emanating from the bud-site provide tracks along which type V myosin coated 
vesicles ply, delivering cargo essential for polarized growth, segregation of organelle, 
cell wall synthesis etc (Moseley and Goode, 2006). 
 Cables, unlike patches, assemble in an Arp2/3 independent manner. The actin 
nucleating activity of formins and profilin are of paramount importance in the 
formation of actin cables in yeast. Formins, Bni1p and Bnr1p, are potent actin 
nucleators that are essential for cable formation (Kovar and Pollard, 2004). Deletion 
of BNI1 gene causes large, unpolarized cell growth with cytokinesis defects. BNR1 
deletion is less deleterious to the cells but when combined with conditional mutants of 
BNI1, all visible actin cables are lost at non-permissive temperature. C-terminal FH 
(formin homology) 1 and 2 domains of Bni1p can directly nucleate actin in vitro. 
Studies in mammalian cells show that formins are usually found in a closed, 
autoinhibited form in vivo. The inhibition is relieved upon binding of activated Rho-
GTPases to the N-terminal portion of formins. In yeast, it has not yet been determined 
whether or not Bni1p and Bnr1p are autoinhibited but they do bind to various 
activated GTPases such as Cdc42p, Rho3p and Rho1p.  
CHAPTER I INTRODUCTION 
16 
 Cables provide polarized tracks for myosin-fuelled transport of vesicles to bud 
neck and tip. Hence the cables must maintain uniform polarity through out its length. 
Earlier, cables were thought to be stable structures consisting of long actin filaments 
that persist over a long period of time. However recent studies have shown that cables 
are assembled by bundling together short, actin filaments of uniform polarity, which 
are highly dynamic in nature. The barbed ends of these filaments are oriented towards 
polarity sites. Various filament-binding proteins are known, some of which have 
stabilizing activity while others induce depolymerization. Actin bundling proteins 
such as Sac6p and Abp140p can be found coating the actin cables, and bind actin 
filaments together to form a cable. The exact mechanism and the regulation of their 
activities are not known. The yeast capping proteins Cap1/2 bind to barbed ends of 
filaments, preventing assembly or disassembly of the filament, thereby stabilizing the 
cable size. The exact mechanism of actin cable dynamics, size and positioning are not 
known. 
1.1.5.2 Acto-myosin ring 
Cytokinesis, the separation of two divided cells, is brought about by contraction of an 
actin based contractile ring. This ring is conserved from yeast to mammals. In animal 
cells, myosin II provides the contractile force required to squeeze the membrane and 
separate the two daughter cells. In yeast, the function of Myo2p at the cytokinetic ring 
has similar function in pinching off the daughter cell and mother cell at the 
completion of cell division.  
 In S.cerevisiae, the acto-myosin ring begins to assemble early in G1 phase, 
after the bud site has been selected and the bud begins to emerge. The early bud 
position cues help in recruiting factors essential for the bud neck. Proteins such as 
Myo1p, the formins Bni1p and Bnr1p, myosin light chains Mlc1p and Mlc2p etc 
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assemble at the neck. During anaphase, the actin cables formed reorient in such a way 
that they direct secretory vesicles towards the neck, leading to massive membrane and 
cell wall deposition and assembly of the septin structure. Simultaneously, an actin 
ring begins to form, which eventually, in a Myo1p-dependent manner, will aid in 
closing of the neck (Vallen et al, 2000). 
 
1.2 Endocytosis 
Endocytosis is a vital process by which cells intake nutrients and signaling molecules 
etc from the environment and also recycles cell membrane associated receptors and 
lipids. This is usually achieved my membrane remodeling-usually invagination in the 
case of fluid/receptor-mediated endocytosis or membrane protrusion in the case or 
phagocytosis- followed by vesicle scission and its subsequent internalization (Drubin 
et al. 35-42). The different types of endocytosis include: phagocytosis (cell eating), 
pinocytosis (cell drinking) and receptor mediated endocytosis. The first two are 
limited to more complex eukaryotic cells like macrophages but receptor mediated 
endocytosis is conserved all the way from simple eukaryotes like S.cerevisiae to 
humans (Figure 1.6 used with permission from Kaksonen et al 2006).  
 1.2.1 Clathrin mediated endocytosis 
Clathrin mediated endocytosis (CME) is one the most important and well 
characterized mode of endocytosis, which is conserved in most eukaryotic cells. The 
basic schematic of CME is well established. The first step consists of binding of 
extracellular cargo (e.g. amino acids, pheromones, metal ions) to their specific cell-
surface receptors. Upon cargo/ligand binding, clustering of these receptors take place 
on the cell membrane, which are usually mediated by a variety of adaptor proteins. 
Subsequently, clathrin is recruited and combined with the adaptor proteins form the 
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endocytic coat at the plasma membrane. This coat facilitates the formation of the 
invagination of the lipid bi-layer with the help of localized actin polymerization. The 
membrane then pinches off, encapsulating the cargo and receptors, to form a clathrin 
coated vesicle (CCV). The coat is rapidly dissembled upon internalization and 
recycled back to the cell periphery (Kaksonen, et al 2006). The CCV then fuses with 
early endosomes and the receptors are shunted to a degradation pathway and/or 
recycled back to the membrane. 







Figure 1.6 Types of endocytosis in yeast and mammalian cells 
The various types of internalization processes are depicted in this cartoon. Mammalian cells 
undergo several types of internalization namely phagocytosis 9engulfing of large particles), 
pinocytosis (cell drinking), clathrin-mediated endocytosis and caveolin-mediated endocytosis. 
Actin structures are found to be intimately associated with endocytosis as shows by the red 
bars. I S.cerevisiae is a much simpler organism and only CME has been well characterized. 
The various actin structures are depicted in red, in the yeast cells 
Reproduced with permission from publisher from Kaksonen et al, 2006 Nature Reviews 
Molecular and Cell Biology, Volume 7. 
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1.2.2 Endocytic Coat Proteins 
 1.2.2.1 Clathrin    
Clathrin is a protein that is conserved in all eukaryotes from yeast to mammals. The 
basic clathrin module consists of two subunits namely the heavy and light chains, 
which polymerize into a “triskelion” which consists of 3 copies of the clathrin 
modules. This triskelion in turn oligomerizes into a basket like structure around cargo 
proteins at cell membrane and forms the clathrin-coated pit. These pits appear as 
dense sub structures in EM sections of cell membranes. The main function of the 
clathrin skeleton is to maintain curvature of the membrane and helps in formation of 
vesicles. 
In S.cerevisiae, CHC1 encodes the clathrin heavy chain and CLC1 the light chain. 
Deletion of either gene causes profound defects in endocytosis but does not eliminate 
it completely. In contrast, mammalian cells are almost completely blocked in 
endocytosis when either clathrin heavy chain or light chain is knocked down. 
1.2.2.2 Sla1p 
Sla1p is an endocytic adaptor protein that was discovered as a gene whose deletion 
was synthetically lethal with abp1. Sla1p is a multivalent protein required for 
endocytosis and actin organization (Ayscough et al, 1999). Its domain architecture 
consists of three SH3 domains in its N-terminal and a stretch of proline, glycine and 
threonine repeats (Sla1 repeat or SR) in its C-terminus. This stretch contains multiple 
Prk1/Ark1 phosphorylation motifs. Phosphorylation by Prk1p dissociates Sla1p from 
the Pan1p-End3p-Sla1p trimeric complex important for actin organization. Sla1p is 
also an important adaptor protein, which mediates several important protein-protein 
interactions such as with Abp1p and Las17p. Sla1p has been shown to inhibit the NPF 
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activity of Las17p. It is one of the early proteins to be recruited to the site of 
endocytosis as it can bind cargo proteins containing the NPF motif (asparagines-






The detailed function of Pan1p is described in the section dealing with Nucleation 
Promoting Factors. Pan1p, in addition to its function as an NPF, also acts as an 
important scaffolding protein. It interacts with Sla1p and End3p (Zeng et al, 2001), 
Sla2p (Toshima et al 2007) and type I myosins (Barker et al, 2007). Its NPF ability is 
negatively regulated by interaction with Sla2p (Toshima et al, 2007) as well as 
phosphorylation by Prk1p (Toshima et al, 2005). 
Figure 1.7 Cartoon depicting the trimeric complex between Pan1p, Sla1p, End3p and Scd5p and the 
dephosphorylation of Pan1p by Glc7p. Sla1p (purple ovals) separates from Pan1p and end3p upon 
phosphorylation. Phosphorylated Pan1p gains access to the phosphatase by Scd5p binding to End3p and 
being brought to close proximity to Pan1p. (Modified with permission from publisher from Zeng et al, 
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1.2.2.4 yAP1801 and yAP1802 
yAP1801 and yAP1802 are yeast homologues of mammalian CALM/AP180 proteins. 
This family of proteins is characterized by the presence of an N-terminal lipid binding 
motif known as the ANTH domain (AP180 N-terminal homology), which is 
structurally similar to the ENTH domain found in epsins and their homologues. The 
yeast AP180 proteins also contain 5 EH domain-binding NPF (asparagine-proline-
phenylalanine) motifs and a clathrin-binding motif (CBM). These proteins are found 
to localize to endocytic plasma membrane patches. In mammalian cells, AP180 is 
found exclusively in neuronal, synaptic membranes and functions in endocytic 
recycling of synaptic vesicles. It has been shown to bind actin and promote its 
assembly into cages. CALM proteins are universally expressed in all other cell types 
and are thought to perform similar functions. In yeast, the clathrin assembly functions 
of yAP1801/2 have not been shown directly and these two are inessential for viability 
(Huang et al, 1999 and Maldonado-Baez et al, 2008). They are thought to have a 
redundant role with Ent1/2p proteins, discussed below. 
 
1.2.2.5 Ent1p and Ent2p 
Ent1p and Ent2p are putative adaptor proteins belonging to the epsin family, which by 
definition, contain a globular ENTH (epsin N-terminal homology) domain that binds 
phosphotadylinositol-4,5-bisphosphate lipid present abundantly in the plasma 
membrane. The C-terminal region consists of 2 UIM (ubiquitin interaction motif) that 
recognize membrane receptors, which are mono-ubiquinitated. In addition, they bind 
to EH (epsin homology) domain-containing proteins such as Pan1p and Ede1p via 
their 2 NPF domains. The presence of a CBM at the C-terminal makes these attractive 
clathrin adaptor candidates. Deletion of either Ent1p or Ent2p is not deleterious to the 
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cell, but ablation of both renders the cell inviable. These proteins have overlapping 
functions with yAP1801/2 in clathrin mediated endocytosis, thought their roles are 
poorly understood (Wendland et al, 1999).    
1.2.2.6 Scd5p 
Scd5p was first identified in a screen for high-copy suppressors of clathrin heavy 
chain (CHC1) deletion, is essential for survival (Nelson et al, 1996). It plays an 
important role in actin cytoskeleton organization as well as endocytosis, as 
temperature sensitive mutants are defective in both. Scd5p contains two PBMs 
(Phosphatase binding motifs) in its N-terminus that are responsible for interacting 
with Glc7p, the yeast protein phosphatase-1 (Chang et al, 2002). Scd5p physically 
interacts with several components of the actin and endocytic machinery (Figure 1.7), 
like Pan1p, clathrin, Sla2p and End3p (Henry et al, 2002, Zeng et al, 2007). By the 
virtue of its interaction with these modules as well as Glc7p, it has been hypothesized 
that Scd5p is the targeting subunit for the phosphatase as far as the cell cortex is 
concerned. The phosphorylation/dephosphorylation of key players in these pathways 
is an important mode of regulation of actin polymerization and internalization. 
 1.2.2.7 Sla2p/HIP1/R 
The main focus of this thesis is an important adaptor protein called Sla2p, which is 
conserved all the way from fungus to mammals. In the following sections we describe 
the function of this protein in yeast as well as higher vertebrates. 
1.2.2.7.1 Sla2p 
Sla2p was identified independently in two different screens: one screening for 
proteins synthetically lethal with abp1  (Sla2: Synthetic lethal with abp1) [Drubin 
et al, 1988] and the other screening for null mutants defective in endocytosis of alpha-
factor receptor Ste2p (End4: endocytosis defective gene) [Raths et al, 1993].  
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The sla2 strain is unable to grow at temperatures above 34oC. The mutant 
cells contain large, abnormal actin structures containing filamentous actin and are also 
severely blocked in receptor- and fluid-phase endocytosis. The abnormal actin 
structures also co-localize with other important endocytic and actin-regulatory 
proteins such as Abp1p, Pan1p, Sla1p, Ent1p and clathrin. The presence of these actin 
clumps seems to show that Sla2p functions in curtailing actin polymerization at the 
cortical patch, which if performed in a timely manner, allows for internalization of 
endocytic vesicles (Kaksonen et al, 2003). Ablation of the SLA2 gene results in over-
polymerization of actin, which leads to a complete block in endocytosis and 
accumulation of vesicles at the cell periphery. Visualization of the abnormal actin 
structures using live-cell, time-lapse microscopy revealed comet-like structures 
emanating from the cell periphery (Kaksonen and Drubin, 2003). One end of the 
comet tail was anchored to the plasma membrane while the other end waved around 
in the cytoplasm. There was no inward movement of the actin patch as observed in 
wild type cells. The comet tails were also found to co-localize with important 
endocytic markers such as Sla1p, Las17p and Pan1p in addition to cargo protein 
Ste2p. This suggests that the comet tails represent a blocked endocytic sites. The 
authors surmised that Sla2 perhaps functions in ensuring that the association between 
endocytic vesicle and actin polymerization machinery is transient. In its absence, the 
normal dynamics is disrupted and endocytosis is completely blocked. Further 
corroborating this, Newpher et al in 2005 reported that clathrin accumulated in the 
comet tails found in sla2 mutants. 
Sla2’s domain architecture consists of an N-terminal ENTH domain that has 
been shown to interact with phosphoinositidol-4,5-bisphosphate. Its C-terminal 
domain (720-968 amino acids) sows significant homology to filamentous actin 
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binding protein Talin and has been shown to bind actin via its I/LWEQ actin-binding 
motif. In addition, Sla2p has three predicted coiled-coil domains from amino acids 
360-580, 700-730 and 930-960 amino acids. The functions of these distinct domains 
are described below.  
 
 
                                      Figure 1.8 Schematic showing the different domains of Sla2p 
 
ANTH domain of Sla2p: ENTH/ANTH domains is a stretch of ~150 amino acids 
that has been found to interact with the phosphoinositide PtdIns(4,5)P2, which is the 
most abundant phosphoinositide in the plasma membrane. This motif is usually found 
is many endocytic and plasma membrane associated proteins and is fairly conserved 
from yeast to humans. The ENTH domain forms an alpha helix, which has been 
shown to interact with the lipid bilayer and imparts membrane curvature by displacing 
lipid head groups. However the ANTH domain differs slightly as it does not form the 
above mentioned alpha helix upon PtdIns(4,5)P2 binding. The exact function of the 
ANTH structure is not yet known. Other proteins that contain this domain are 
mammalian and yeast homologues of AP180 and HIP1 – the mammalian Sla2 
homologue. Sun et al (2005) showed that Sla2’s ANTH domain binds specifically to 
PtdIns(4,5)P2 and this binding is dependant on 4 conserved lysine residues at 
positions 14, 24, 26 and 62. Mutations of these lysine residues to alanine caused loss 
of lipid binding. Deletion of the N-terminal ANTH domain or even mutation of 
conserved K residues to A, cells to be inviable at 34
o
C or higher. The mutant cells 
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also showed a severe reduction in both receptor-mediated and fluid-phase endocytosis 
at non-permissive temperatures as well as 25
o
C. In sla2-4KA and sla2-ANTH cells, 
the actin patch turnover was disrupted. Actin patches were depolarized to mother 
cells, were more abundant and cells seemed more elongated in shape. Live cell 
imaging showed that in sla2-4KA cells, the patches were more elongated than 
punctate and their turnover was two times slower than in WT cells. sla2-ANTH cells 
showed a more severe phenotype consisting of actin comet tails, highly reminiscent of 
sla2 cells. However, both the mutant proteins were correctly localized to cortical 
patches at the cell periphery. Thus the ANTH domain of Sla2 is essential for its 
function in endocytosis and actin patch dynamics but does not affect its localization to 
the cortex. 
Coiled-coil domains: Sla2p contains 3 putative coiled-coil domains of which only the 
first one has been closely studied. The first coiled coil domain extends from amino 
acids 360-580 and is essential for Sla2p function and localization. This domain 
mediates several important protein-protein interactions with Sla1p (Gourlay et al, 
2003), Pan1p (Toshima et al, 2007), Clc1p (Henry et al, 2003) and itself (Yang et al, 
1999). Sla2p exists as a dimer in the cell and deletion of the central coiled domain 
abrogates dimerization. Deletion of this region causes inviability at 37
o
C 
accompanied by abnormal “round” morphology and cell size reminiscent of sla2.  
The mutant protein missing the central coiled-coil domain appears in cortical punctate 
structures although significant amount of signal can be seen diffused in the cytoplasm. 
This region is critical for endocytosis as deletions renders the cell unable to take up 
Lucifer Yellow dye even at temperatures permissible for growth (Yang et al, 1999). 
C-terminal talin-like domain: The extreme C-terminus of Sla2p (amino acids 768-
968) consists of a talin-homology region. Talin is a mammalian protein, which binds 
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to filamentous actin, and the talin-homology domain is found in several actin binding 
proteins including Sla2p’s mammalian orthologues HIP1 and HIP1R. This domain 
consists of the I/LWEQ motif that has been shown to bind filamentous actin and is 
conserved from yeast to metazoans. Deletion of the C-terminal of Sla2p does not have 
profound effect on growth at high temperatures but cells show a marked reduction in 
receptor-mediated endocytosis at 37
o
C. Fluid-phase endocytosis was however 
unaffected.  
1.2.2.7.2 HIP1 and HIP1R 
HIP1 and HIP1R are the mammalian homologues of Sla2 in mammalian cells. HIP1 
was isolated as interacting partner of Huntingtin, the protein whose aggregation is 
implicated in the progress of Huntington disease. HIP1R (HIP1-related) was isolated 
by its homology to HIP1. These proteins are highly homologous and contain many 
similarities in domain architecture but display different localizations and functions in 
the cells. The various cellular roles of the HIP proteins are discussed below. 
 
 
Role in endocytosis and trafficking           
There are many similarities and dissimilarities between functions and properties of 
HIP1 and HIP1R in mammalian cells. For instance, HIP1R but not HIP1, is able to 
co-localize with actin and is localized to membrane ruffles (Hyun and Ross, 2004) 
Figure 1.9 Domain architectures of Hip1 and Hip1R 
CHAPTER I INTRODUCTION 
28 
while only HIP1 co-sediments and binds with clathrin-coated vesicles. Both proteins 
show punctate cytoplasmic staining and are able to bind clathrin light chain via their 
central coiled-coil domains and induce clathrin assembly in vivo, but only HIP1 
contains the consensus binding motif for AP2 (DPF box) as well as the clathrin-heavy 
chain binding motif (clathrin box: LMDMD). HIP1 and HIP1R are able to 
heterodimerize in vivo via their central coiled-coil domains and effectively function 
as a heterodimer. N-terminal of both proteins folds into an ANTH domain, which 
modulates interactions with specific phospho-lipids found in the membrane. HIP1’s 
ANTH preferentially binds to PtdIns(3,4)P2 and PtdIns(3,5)P2, the phosphoinositides 
enriched in early endosomes. This suggests that in addition to the internalization 
process, HIP1 functions in downstream pathways of vesicle movement (Hyun and 
Ross, 2004). On the other hand, HIP1R is found at CCV originating from the TGN.  
Knock down of HIP1R by RNA interference (RNAi) in HeLa cells resulted in 
disruption of Golgi organization and accumulation of F-actin structures associated 
with CCV at trans-golgi network (TGN) (Carreno et al, 2004). Depletion of this 
protein also cause slowing down of cathepsin D (an enzyme that is transported from 
the Golgi) exit from TGN. Silencing of the HIP1R gene using RNAi caused a block in 
internalization and also accumulation of abnormal cortical actin structures such as 
actin tails, rings and other complex structures. These abnormal structures were found 
to form stable associations with CCVs and CCPs, dynamin, Arp2/3 complex and 
cortactin. (Engqvist-Goldstein et al, 2004).  
Role of HIP1 in the nucleus and in tumor progression 
HIP1 contains a classical NLS (nuclear localization signal) in its C-terminus. It is 
found to shuttle to the nucleus constitutively as well as upon stimulation by androgens 
(Mills et al, 2005). The mechanism of its exit from the nucleus is currently unknown. 
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HIP1 directly binds to the androgen receptor (AR) in the cytosol and translocates to 
the nucleus at an accelerated rate upon androgen binding.  
Once inside the nucleus, HIP1 acts in concert with AR and co-activates 
transcription of genes whose non translated regions contain the androgen responsive 
elements (ARE). HIP1 has been shown to stimulate transcription in in vitro reporter 
assays and also co-immunoprecipitated along with ARE and AR (Mills et al, 2005). 
HIP1 is implicated in decreasing the rate of AR degradation, thereby prolonging 
cellular response to androgen. In addition to androgen response, HIP1 was found to be 
able to co-activate receptors of estrogen and glucocorticoids as well.  
HIP1 expression is important for cell survival and is upregulated in many 
tumor cells studied including breast, ovarian, prostrate, lung and colon cancers. 
Increase in HIP1 levels are associated with poorer prognosis of men suffering from 
prostrate cancer (Hyun and Ross, 2004). This correlates to Hip1’s function in 
activation of transcription of ARE containing genes, which are usually pro-cell 
proliferation. HIP1R is not found to have any nuclear function or localization and is 
usually not upregulated significantly in tumors. 
Insights from mouse knockout studies 
HIP1 and HIP1R knock out (KO) mice strains have been well studied. Single HIP1R 
KO mice have very subtle phenotypes. They show depletion of acid secreting parietal 
cells that ultimately lead to asymptomatic gastric hyperplasia and intestinal 
metaplasia in mice (Jain et al, 2008). HIP1 KO mice show male infertility due to 
apoptosis of post meiotic spermatids (Rao et al, 2001), increased incidence of 
cataracts due to premature cell death in the lens (Oravecz-Wilson et al, 2004) and 
kypholordosis (spinal defects) by the age of one (Metzler et al, 2003).  
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Interestingly, mouse embryonic fibroblasts (MEF) isolated from these knock 
out mice show very little defect in endocytosis, actin organization or signaling 
patterns compared to wild-type mice. Growth and survival of these cells in culture 
also did not differ greatly from wild-type derived MEFs. This is in direct contrast with 
knock down experiments performed with RNAi, where severe defects in endocytosis, 
actin dynamics and nuclear hormone-receptor signaling were observed. This seems to 
suggest that increased level of compensation by the related protein is observed in 
single HIP1 or HIP1R knock out mice.  
Double knock out (DKO) mice of HIP1 and HIP1R were recently generated and their 
phenotypes characterized (Bradley et al, 2007). These mice showed more severe 
kypholordosis and severe weight loss due to metabolic failure and premature death of 
the animals. However, MEFs from the DKO mice showed no disruption of nuclear 
hormone function, receptor stability or actin dynamics. Hence at least some functions 
of the HIP1/R family can be compensated by other proteins but overall function in 
cell survival of gastric and neuronal cells are lost in DKO. It will be interesting to 
know which genes are upregulated in order to maintain actin dynamics and 
endocytosis in these DKO mice. 
1.2.2.8 Vesicle Scission 
After the capture of cargo, assembly of clathrin cage and endocytic coat and the 
initiation of actin polymerization, it is necessary for the endocytic vesicle to secede 
from the plasma membrane and continue its journey to the centre of the cell. Vesicle 
scission is a very poorly understood process in both yeast and higher eukaryotes. 
Many proteins are considered to play overlapping roles. Actin polymerization is also 
thought to play an important role in this process, as branched actin filaments below 
the plasma membrane are thought to cause physical deformation of the membrane, 
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ultimately leading to curvature, pinching off and vesicle formation. Below are the 
various proteins implicated in the last step of vesicle formation (Moseley and Goode, 
2006). 
• Dynamin family:  is a family of large GTPases implicated in vesicle formation. In 
mammalian cells, dynamin is implicated in binding to the neck of the budding vesicle 
and providing the chemical force required to close off the membrane that allows the 
membrane to pinch off. In mammals, dynamin is also involved in phagocytosis, 
caveolae-mediated endocytosis and cytokinesis. Yeast cells do not have a “classical” 
dynamin homologue but Vps1p and related proteins like Mgm1p and Dnm1p have 
dynamin-like GTPase domains but lack other protein interaction domains. Vps1p does 
not behave similarly to its mammalian counterpart and functions more at the TGN 
than plasma membrane. However, Vps1p has been shown to play a role in actin 
cytoskeleton organization as well as endocytosis (Yu and Cai, 2004). 
• Synaptojanins: belong to a family of lipid phosphatases that regulate the levels of 
phosphoinositides (PI) at the membranes. PI’s are short-lived lipids with important 
signaling functions in processes such as cell proliferation, actin cytoskeletal 
rearrangements and vesicular traffic. Membranes of different origins have different 
compositions of PI’s: for eg, phosphoinositol-4-P is enriched in Golgi-derived 
membranes while phosphatidylinositide-4,5-bisphosphate is the most prevalent PI in 
plasma membrane. PI’s are known to alter the properties of membranes and also 
increase the affinity of peripheral membrane proteins for the membrane. Adjustments 
in levels of PI’s play a role in attracting proteins to the membrane in a controlled 
manner. PI-sensitive proteins usually play a role in cargo sorting, docking and fusion 
of vesicles etc. Many phosphatases and lipases play an important role in maintaining 
the levels of PI at the membranes. Synpatojanins are one such class of proteins, 
CHAPTER I INTRODUCTION 
32 
conserved from yeast to mammals. In yeast, there are three synaptojanins – Sjl1p, 
Sjl2p and Sjl3p with some redundancy. Deletion of single genes or combinations of 
double deletions are viable although deletion of all three genes causes impaired cell 
growth, defects in receptor-mediated and fluid-phase endocytosis, actin 
disorganization and abnormal plasma membrane morphology with massive, 
unattenuated invaginations (Singer-Kruger et al, 1998, Stefan et al, 2005)). Many 
cytoskeleton proteins show genetic interactions with synaptojanins: t.s mutants of 
PAN1 and deletion of SAC6 show synthetic lethality with sjl1 while sjl3 in 
combination with t.s alleles of CHC1 show profound defects in clathrin-dependant 
sorting at the TGN. A mutant of Sla2p, which is no longer able to bind to PI’s and is 
temperature sensitive at 37
o
C, is rescued by sjl1 (Sun et al, 2005). Thus lipids and 
their regulators play an important role in endocytosis, in particular vesicle scission. 
 Rvs161/Rvs167p: were originally identified as protein required for growth in 
reduced nutrients. They are homologous to amphiphysins in higher eukaryotes. These 
proteins are a member of a larger family called BAR-domain containing proteins on 
the basis of presence of a BAR domain (Ren et al, 2006). Deletion of these mutants 
while not deleterious for growth, cause severe actin abnormalities such as depolarized 
patches, abnormal budding and compromised endocytosis. Electron microscopy 
studies of these mutants reveal accumulation of secretory vesicles at sites of 
membrane and cell wall reconstruction. The BAR domain binds preferentially to 
highly curved
 
negatively charged membranes in vitro, and this property is
 
thought to 
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1.2.2.9 Proteins regulating Clathrin-mediated endocytosis  
Ark1p/Prk1p family of kinase: consists of three members in S.cerevisiae namely- 
Ark1p, Prk1p and Akl1p. These were classified according to sequence homology to 
their N-terminal kinase domains, which are well conserved while their C-terminal 
regions are divergent. These proteins have very specific functions in actin cytoskeleton 
regulation and endocytosis. Homologues have been identified in other organisms 
including humans and now constitute a super-family of kinases.  
 Ark1p (actin related kinase) was discovered in a screen for proteins that 
interacted with C-terminal portion of Sla2p (Cope et al, 1999). Prk1p was isolated 
independently by two labs: as an extragenic suppressor of the pan1-4 mutation (Zeng 
and Cai, 1999) and by homology to Ark1p kinase domain (Cope et al, 1999). Prk1p is 
the better characterized member of this family. It is specifically a threonine kinase 
and has similar conserved characteristics to other serine/threonine kinases, such as the 
conserved lysine in subdomain II (K56) and conserved aspartate in subdomain VIb 
(D158). The kinase domain constitutes about 280 amino acids in the N-terminal 
domain.  








The C-terminal consists of a proline-rich region that is important for binding to the 
SH3 domain. This motif has been shown to be important for its localization to the 
Figure 1.10 Prediction modeling of the structure of Prk1p kinase and the surfaces that bind to the 
recognition motif 
A and B: show the kinase domain highlighting the various domains important for kinase activity. 
Aspartic acid residue at position 158 is crucial for kinase activity 
C: A closer look at the putative interactions between the consensus motif (in black) and the various 
points of contact between the recognition sequence and the amino acids in the kinase (in red). 
(Reproduced with permission from publisher from Huang et al, 2003 Molecular Biology of the Cell, 
Volume 14, Issue 12) 
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cortical patches. Interestingly, Prk1p contains a bipartite nuclear localization signal 
(NLS) of unknown significance, as the protein is not commonly seen in the nucleus.  
 Both in vitro and in the cell, Prk1p behaves as a threonine kinase (Zeng and 
Cai, 1999, Huang et al, 2003). The recognition motif of Prk1p has been thoroughly 
characterized and was found to be of the sequence [L/I/V/M]xx[Q/N/T/S]xTG, where 
x stands for any amino acid. The penultimate residue, threonine, is specifically 
phosphorylated by the kinase. The glycine present just after the threonine (denoted as 
P+1) is necessary for recognition and phosphorylation by Prk1p. The fifth residue 
upstream of threonine (P—5) site is restricted to a hydrophobic residue -leucine, 
isoleucine, valine or methionine. The P—2 site can afford a degree of flexibility and is 
not restricted to any particular amino acid (unpublished results, CMJ lab). Mutating the 
conserved D158 of K56 residues can completely eliminate the kinase activity of Prk1p.  
 The substrates of Prk1p include many proteins that are involved in actin 
regulation and endocytosis, such as Pan1p, Sla1p and Scd5p as mentioned earlier. The 
kinase activity of Prk1p is important for its function, as the kinase-dead protein is unable 
to rescue the temperature sensitivity of ark1prk1. Deletion of any single kinase of the 
family does not yield an observable phenotype, suggesting that there is some 
redundancy in function. Ablation of both Ark1 and Prk1 shows restricted growth at 
37oC and severe actin disorganization in the form of actin clumps as well as drastic 
reduction in endocytosis. Moreover, localization of many of its substrates such as Pan1p 
and Sla2p are disrupted in the double deletion cells (Cope et al, 1999, Sekiya-Kawasaki 
et al, 2003). On the other hand, massive over expression of Prk1p is cytotoxic, resulting 
in aberration in the actin cytoskeleton. Ark1p and Akl1p over expression do not have 
deleterious effects on the cell (Cope et al, 1999, Jin and Cai, 2008).  
 Phosphorylation of Prk1p targets is largely thought to have a negative, 
regulatory effect on the activity of the protein. For instance, Pan1p, the best studied 
substrate of Prk1p, is phosphorylated at multiple sites. Over-phosphorylation of Pan1p 
causes it to dissociate from a complex with Sla1p but not End3p (Zeng et al, 2001, 
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Toshima et al, 2005). This charged modification also renders it incapable of activating 
the Arp2/3 complex (Toshima et al, 2005). 
 Ark1p is less well characterized compared to Prk1p. Its exact substrate 
preference is unknown but is thought to be similar to its homologues. Sla1p was 
recently shown to be preferentially phosphorylated by Ark1p (Jin and Cai, 2008). The 
C-terminal portion of Ark1p is divergent from Prk1p. Ark1p is capable of interacting 
with Sla2p (Cope et al, 1999) and in this study I went on to investigate the role of this 
interaction in regulating endocytosis and actin cytoskeleton reorganization.  
 Glc7p: is an yeast type 1 protein phosphatase involved in diverse cellular 
processes such as glycogen metabolism, translational control, glucose repression etc. 
In the context of endocytosis and actin organization, its binding to its regulatory 
subunit plays a very important role (Chang et al, 2002). Loss of binding to Scd5p 
causes temperature sensitive growth and aberrations in actin cytoskeleton. Loss of 
Glc7p function causes increased phosphorylation levels of Pan1p, Sla1p as well as 
Scd5p (Zeng et al, 2007). This phosphatase has been shown to act antagonistically to 
the Ark1/Prk1 kinase family and along with it regulates the endocytic cycle.  
 
1.2.3 Endocytic Signals  
Clathrin-mediated endocytosis is the major pathway for ligand-bound receptors, as 
described earlier. Several targeting signals are present in the receptors, which upon 
ligand binding, undergo post-translational modification and trigger the internalization 
process. These signals are short, well-defined sequences found in the cytosolic region 
that help in recruitment of adaptor proteins.  
 In mammalian cells, two classes of such signals exist: the tyrosine-based motif 
and the di-leucine-based motif. In S.cerevisiae, the internalization signals are different 
from that of animal cells. The best characterized signals are of the form NPFXD and 
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DAKSS, present in Ste3p and Ste2p receptors respectively. These amino acid 
stretches are essential for endocytosis of these pheromone receptors. Sla1p is the 
adaptor that binds these recognition sequences and recruits the rest of the coat to the 
cargo. 
 
1.2.4 Role of actin dynamics in endocytosis 
Role of actin in endocytosis had been widely suspected but only recent technological 
advances in live cell imaging have been able to show a direct and co-operative model 
involving cargo recruitment, CME and actin polymerization. Early evidences in 
S.cerevisiae hinted that actin plays a vital role in endocytosis. Actin poisons such as 
Latrunculin A (binds monomers and prevents their incorporation into filaments) and 
jasplakinolide (stabilizes filaments and prevents depolymerization) caused a complete 
block in endocytosis, suggesting that a dynamic actin cytoskeleton is necessary for 
this process. In addition, actin and actin regulatory proteins had been long implicated 
in endocytic screens. Mutations in the ACT1 gene were identified in screens for 
endocytic mutants and other actin regulatory protein such as Sac6p (fimbrin 
homologue) and Myo5p showed profound endocytic defects.  A host of protein-
protein interactions have been characterized between members of the actin machinery 
and the various endocytic coat components. A combination of these data added to the 
mounting evidence that actin was indeed involved in endocytosis. However, only after 
the development of very sensitive live-cell imaging techniques, could a visual link be 
determined (Kaksonen et al 2003). Evidences from both mammalian and yeast cells 
using various elegant live-cell microscopy techniques show that actin polymerization 
begins when membrane invagination starts and total polymerization stops once 
vesicle scission is complete (Kaksonen et al 2003). This process is precisely 
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choreographed and involves an intricate network of proteins that act in concert or in 
sequence to bring about the processes of actin polymerization and vesicle 
internalization. Actin has been shown to play a role in almost every step of the 
internalization process. 
  Endocytic coat and actin nucleation: The endocytic coat complex marks out 
the prospective site of endocytosis. Additionally, newly identified sub structures 
called eisosomes are all thought to be pre-endocytic sites, distinct or sometimes 
overlapping with coat proteins (Moseley and Goode, 2006). As described in an earlier 
segment, early endocytic proteins such as Sla1p, Sla2p and Pan1p mark out the 
presumptive endocytic site (Smythe and Ayscough, 2006). Clathrin is recruited to 
these sites or pre-assembles and in turn recruit members of the coat complex (Henry 
et al, 2005). Actin structure in both yeast and mammalian cells are first associated 
with the step just prior to internalization, after the formation of the endocytic coat. 
Subsequent steps of endocytosis are also intimately connected with actin. A burst of 
actin polymerization occurs just before the scission of the vesicle from the membrane, 
in both mammalian and yeast cells. Actin filaments and activators of actin 
polymerization have also been shown to direct clathrin coated vesicle in a lateral 
manner to specific sites although in an indirect manner.  
 What happens when actin polymerization is blocked?  Yeast and mammalian cells 
respond differently to disruption of normal actin cytoskeleton with respect to 
endocytosis. 
Using Lat A, an actin-depolymerizing drug, was shown to inhibit endocytosis, almost 
completely. Recently, Kaksonen et al (2004) showed that upon Lat A treatment, 
clathrin coated vesicles accumulated at the cell periphery, along with other endocytic 
coat proteins such as Sla1p, Sla2p, Pan1p etc. The loss of a dynamic actin 
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cytoskeleton-consisting of both polymerization as well as actin turnover- completely 
blocked internalization. Very similar phenotypes are obtained with conditional 
mutants of members of the Arp2/3 complex. This further strengthens the argument 
that actin polymerization is critical in the early stages of endocytosis. In mammalian 
cells, treatment with a related actin depolymerizing drug- Lat B, caused an 82% 
decrease in endocytosis (Merrifield et al, 2005). Using electron microscope it was 
shown that cultured cells treated with another actin disrupting drug jasplakinolide or 
Lat A, although blocked endocytosis, the surface of the treated cells contained more 
number of invaginations than untreated cells (Yarar et al, 2005). This indicates a 
fundamental difference in the requirement of actin in yeast vs. mammalian cells. In 
budding yeast, actin is absolutely required for the very early membrane invagination 






 1.3 Actin and endocytosis in higher eukaryotes 
Mammalian cells have many different types of endocytosis namely clathrin mediated 
endocytosis, caveolar pathway, clathrin- and caveolar-independent endocytosis and 
phagocytosis. Each pathway is distinct but share some of the same machinery. In this 
section the various types of endocytosis and their dependence on actin is discussed. 
 




1.3.1 Clathrin-mediated endocytosis in higher eukaryotes 
As the name suggests, CME requires clathrin- a triskelion type cytoplasmic protein 
that assembles at endocytosis sites. The three heavy chains and three light chains form 
the core element that eventually oligomerizes into a cage-like structure, similar to that 
in yeast. Adaptor complex AP-2 is recruited to these sites and is thought to integrate 
signals from internalization motifs of cargo proteins (di-leucine/tyrosine motifs), 
phospholipids cues and other endocytic proteins like Eps15. This complex brings the 
endocytic machinery to the clathrin lattices. Other clathrin adaptors include 
CALM/AP180, epsins and Sla1p-homologue HIP1/HIP1R, as these proteins are also 
able to bind clathrin, phospholipids and other proteins.  
 The current model suggests that after clathrin lattices are formed, the 
membrane depresses and invaginates to form a clathrin-coated pit (CCP). These pits 
grow deeper and longer in a process catalyzed by a lysophosphatic acid transferase 
called endophilin. Dynamin, a conserved, large GTPase, assembles in a spiral around 
the neck of the pit, catalyzing the narrowing and eventual pinching off of the clathrin-
coated vesicle (CCV). 
Figure 1.11 Types of endocytosis in higher eukaryotes 
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After release, the CCV begin to move away from the plasma membrane, shed their 
coat and fuse with endosomes.   
Role of actin in mammalian CME: Unlike yeast, actin is not essential for CME in 
higher eukaryotes. However, the actin structure and the machinery do indeed play 
important roles in various steps in endocytosis. Firstly, actin is thought to be involved 
in determining sites of endocytosis. Unlike yeast, mammalian cells do not have 
cortical actin patches. However, clathrin adaptor AP-2 was found to co-localize with 
actin stress fibers close to the plasma membrane (Engqvist-Goldstein and Drubin, 
2003) and are arranged in a linear array. HIP1R is an important point of contact 
between the clathrin lattice and actin in many mammalian cells. This protein is 
discussed in further detail in subsequent sections of this chapter. 
 Studies with several actin-disrupting drugs provided many insights as to the 
degree of actin cytoskeleton’s role in CME. Live cell imaging of cells treated with 
Lat-B, an actin monomer-sequestering drug, revealed increased lateral movement of 
CCP’s along the plane of the plasma membrane (Gaidarov et al, 1999). This suggests 
that actin cables play a role in restraining the endocytic machinery to certain domains 
on the plasma membrane in order to organize the cell cortex and lead to stable 
formation of CCP. This is especially vital for polarized cells, such as epithelial cells 
and neurons, as it allows them to define particular sites from which cargo should be 
internalized. In fact, actin filaments have been found to localize along endocytic sites 
in the synapse of neuronal cells (Shupliakov et al, 2002). 
 Actin cytoskeleton has been proposed to play a role in the later endocytic 
events such as neck constriction, membrane fission, and detachment of CCV. 
Treatment of certain cell lines with Lat-A, an actin filament-disrupting drug, let to a 
block in CME at a step after CCP formation. The inward movement of clathrin-coated 
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structure is concomitant with increase levels of actin at the surface, suggesting that 
actin polymerization might provide the force required to drive endocytic coat 
movement. However unlike yeast, actin does not play an obligatory role in 
endocytosis, as the actin disrupting drugs do not show a drastic reduction in levels of 
endocytosis. Another proposed role of actin at the cell surface could be to provide 
tracks to facilitate myosin VI motor protein mediated vesicle movement and/or 
contractile-force generation (Moseley and Goode, 2006). 
 Several proteins are implicated in bridging the actin machinery with the 
endocytic module (Moseley and Goode, 2006, Engqvist-Goldstein and Drubin, 2003). 
As discussed later, the HIP1/R family plays an important role, as they are able to bind 
to both clathrin as well as actin, along with other endocytic proteins such as the AP-2 
complex. Eps15, which is related to yeast Pan1p, functions in recruiting various 
adaptor proteins such as Ap-2, epsins, intersectin and synaptojanin, to the clathrin 
lattice. Unlike its yeast counterpart, Eps15 cannot directly activate Arp2/3 complex 
but instead regulated actin assembly via N-WASP and Cdc42, functioning as a bridge 
between actin and endocytosis. 
1.3.2 Caveolae-mediated endocytosis 
In animal cells, there have long been evidences of clathrin-independent internalization 
pathways, which are not being studied in great detail. One such method is caveolar 
endocytosis implicated in recycling of glycosphingolipds, GPI-anchored proteins, 
extracellular ligands (folic acid, albumin), bacterial toxins, and unenveloped viruses 
(Engqvist-Goldstein and Drubin, 2003). Structurally, caveolar sites appear as flask-
shaped invaginations on the cell membrane, consisting of a protein coat composed of 
caveolin-1 and caveolin-2. The mechanistic details of this method of internalization 
are not fully known. Dynamin plays a similar role as in CME, it is found to coat the 
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necks of such invagination and is thought to be recruited only after cargo loading into 
the caveolar pits.  
Actin is recruited to caveolae at the time of dynamin recruitment and Lat-A 
treatment reduces caveolar endocytosis by 60% in some cell lines. Similar to CCPs, 
lack of actin caused increased lateral movement of the caveolar pit, suggesting that 
actin plays a scaffolding role in restricted movement and localization of caveolar-
endocytosis proteins. Arp2/3 and N-WASP are potential candidates of actin 
components involved in this process. 
1.3.3 Macropinocytosis 
Macropinocytosis or cell drinking is a process by which the cell engulfs large amount 
of extracellular fluid, forms large vesicles and internalizes them. This process can be 
constitutive or stimulated by growth factors such as epidermal growth factor etc. 
Large membrane protrusions are formed, which reach over and form the pinosome. 
Researchers have speculated that pinosomes acquire actin cytoskeleton machinery 
that propels the crest of the plasma membrane ruffle. The Arp2/3 complex, N-WASP 
and cortactin are known to co-localize with pinocytic vesicles, which in turn are 
associated with actin tails close to the cell surface. These actin tails are similar to ones 
observed during Listeria monocytogenes infection. The actin associated with 
pinocytes were visualized as they transiently polymerized on pinocytic vesicles, 
driving their movement inwards at the speed of ~0.2μm/s (Merrifield et al, 1999). 
Dynamin also was found to be necessary for this process. 
1.3.4 Phagocytosis 
Phagocytosis, often described as  “cell eating”, is the process by which many cells 
internalize particles of size >0.5μm. This process is found in many lower organisms 
such as the amoeba but has been vastly studied in the mammalian immune system. 
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Professional phagocytes such as neutrophils and macrophages routinely engulf large 
particles such as bacteria, viruses and even tumor cells. The link between actin 
polymerization and phagocytosis has been well established (Welch and Mullins, 
2002). Actin polymerization is known to provide the mechanical force required to 
generate membrane protrusions, which reaches over and engulfs the particle during 
cell ingestion.  
 In mammalian cells, several cell-surface receptors are involved in initiation of 
phagocytosis such as the complement receptor-3 (CR-3) and the Fc-receptors, which 
recognize particles coated with iC3b and IgG respectively. CR-3 mediated 
phagocytosis involves activation of the GTPase Rho while Fc-receptor-mediated 
process involves activation of Cdc42, Rac or ARF6.  
 The Arp2/3 complex and several NPFs are important for phagocytosis. WASP 
plays an especially critical role, especially in immune cells, in fact the Wiskott-
Aldrich syndrome where WASP function is compromised, is an immune disorder. 
Macrophages for patients suffering from WA syndrome are incapable of assembling 
actin at the phagocytic cups and are unable to engulf particles efficiently. WASP and 
N-WASP both localize to the phagocytic structures. Arp2/3 complex is enriched at 
these sites. 
 Apart from Arp2/3 complex, phagocytosis also requires the activity of cofilin, 
an actin-depolymerizing factor that binds to ADP-actin and causes 
depolymerization of “old filaments”. Acting in concert with Arp2/3 complex, cofilin 
is thought to play a role in reorganizing actin filaments and help in generating 
barbed ends towards the growing protrusion of the phagocytic edge. In addition, 
myosin VII and I is also thought to aid in force generation. 
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 1.4 Objectives 
In this study I have focussed on the functions of Sla2p in actin organization and 
endocytosis. The first objective was to find out whether Sla2p is subjected to 
regulation by phosphorylation by any of the actin-regulatory kinases- Ark1p or Prk1p. 
Sla2p was known to be phosphorylated in vivo but the importance of this post-
translational modification was unknown. In this study, I wished to understand more of 
the mechanism of function of Sla2p; therefore uncovering the regulatory mechanism 
was of paramount importance. Once it was seen that Sla2p is phosphorylated by 
Prk1p, I studied the effects of this regulation in processes of endocytosis and actin 
organization, along with cortical protein dynamics of Sla2p and its interacting 
partners. Phosphorylation often affects protein-protein interaction and so I wanted to 
see if Sla2p’s affinity for its binding partners were affected by phosphorylation. 
Recently, my lab established a new paradigm in which dephosphorylation was 
shown to be another importance mechanism of regulation at the point of endocytosis. 
The protein-phosphatase-1, Glc7p was specifically targeted to protein phosphorylated 
by Prk1p, via its regulatory subunit Scd5p. Dephosphorylation of Pan1p was shown to 
reactivate the NPF activity, which is usually inhibited by Prk1p phosphorylation. I 
was keen to find out whether Sla2p also underwent similar process. Sla2p is an 
interacting partner for Scd5p and hence seemed like a promising candidate for 
dephosphorylation.   
The function of the Sla2p C-terminal was never comprehensively examined. 
This portion of Sla2p contained several domains such as the THATCH domain and 
two additional coiled-coil domains. In the next chapter, I diverted my focus to the 
second coiled-coil domain in particular. The C-terminal half of Sla2p had been 
implicated in interactions with Ark1p as well as Scd5p, but the exact position and 
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importance of these interactions were not known. One of the objectives was to study 
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 2.1 Materials 
2.1.1 Strains 
STRAINS GENOTYPE 
W303-1A       MATa ade2 can1 trp1 leu2 his3 ura3.  
W303-1B MAT ade2 can1 trp1 leu2 his3 ura3.  
SFY526 MATa ade2 can
r
 trp1 leu2 his3 ura3 lys2 gal4 gal80 URA3::GAL1-
lacZ. [Clontech Laboratories, USA]            
DDY3053 MAT his3-200 ura3-52 leu2-3,112 lys2-801 PAN1-GFP::HIS3 
ABP1-RFP::HIS3 [courtesy of David Drubin] 
YNB40 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 
YNB41 
MAT ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 
YNB16 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2-HA-URA3 
YNB17 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2AA-HA-URA3 
YNB18 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2EE-HA-URA3 
YNB22 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2-EGFP-URA3 
YNB23 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2AA-EGFP-URA3 
YNB24 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2EE-EGFP-URA3 
YNB29 
MAT his3-200 ura3-52 leu2-3,112 lys2-801 PAN1-GFP::HIS3 
ABP1-RFP::HIS3 sla2::SLA2-HA-URA3 
YNB30 









YNB32 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2-HA-TRP1 sla1::SLA1-EGFP-URA3 
YNB33 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2AA-HA-TRP1 sla1::SLA1-EGFP-URA3 
YNB34 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2EE-HA-TRP1 sla1::SLA1-EGFP-URA3 
YNB35 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2-HA-URA3 ark1::ARK1-EGFP-LEU2 
YNB36 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2AA-HA-URA3 ark1::ARK1-EGFP-LEU2 
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YNB37 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::HIS3 pSLA2EE-HA-URA3 ark1::ARK1-EGFP-LEU2 
YNB41 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::SLA2-Myc-TRP1 glc7-ntd [glc7::GLC7-ntd-URA3] 
YNB42 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
sla2::SLA2-Myc-TRP1 glc7-td [glc7::GLC7-td-URA3] 
YNB43  
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
prk1::HIS3 sla2::SLA2-HA-TRP1  
YNB44 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
ark1::LEU2 sla2::SLA2-HA-TRP1 
YNB45 
MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 
prk1::HIS3 ark1::LEU2 sla2::SLA2-HA-TRP1 
YNB46 








pRS304 Integration vector containing TRP1 (Sikorski & Hieter, 1989).  
pRS305 Integration vector containing LEU2 (Sikorski & Hieter, 1989).  
pRS306 Integration vector containing URA3 (Sikorski & Hieter, 1989).  
pRS313 CEN6 HIS3 vector (Sikorski & Hieter, 1989). 
pRS314 CEN6 TRP1 vector (Sikorski & Hieter, 1989).  
pRS315 CEN6 LEU2 vector (Sikorski & Hieter, 1989).  
pRS316 CEN6 URA3 vector (Sikorski & Hieter, 1989). 
pRS424 2μ TRP1 vector (Christianson et al., 1992). 
pRS425 2μ LEU2 vector (Christianson et al., 1992). 
pRS426 2μ URA3 vector (Christianson et al., 1992). 
pGEX-4T-1   Glutathione S-transferase fusion vector (Smith & Johnson, 
1988). 
pGBKT7 2μ TRP1, GAL4 DNA binding domain [1-147 a.a.] [Clontech 
Laboratories.]           
                                                           






Plasmid contains the ORF of the green fluorescent protein 
variant S65T  (Yeast Resource Center, University of 
Washington) 
pBluescript     
     SK (+) 
Vector, CMJ lab collection. 
pNB28 SLA2 coding region including flanking sequences, generated by 
PCR and cloned into pBluescript SK(+) 
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pNB29 SLA2 disruption cassette: PshA1 and EcoRV fragment was 
replaced with HIS3 marker gene 
pNB34 Full length SLA2 gene along with promoter cloned in-frame with 
C-terminal HA tag and ADH1 terminator into pRS316 vector 
pNB35 DNA fragment encoding the full length Sla2p (T329A,T341A) 
along with promoter cloned in-frame with C-terminal HA tag 
and ADH1 terminator into pRS316 vector 
pNB36 DNA fragment encoding the full length Sla2p (T329E,T341E) 
along with promoter cloned in-frame with C-terminal HA tag 
and ADH1 terminator into pRS316 vector 
pNB27 DNA fragment encoding full length Sla2p along with promoter 
cloned in-frame with C-terminal EGFP tag and ADH1 
terminator into pRS316 vector 
pNB57 DNA fragment encoding the full length Sla2p (T329A,T341A) 
along with promoter cloned in-frame with C-terminal EGFP tag 
and ADH1 terminator into pRS316 vector 
pNB58 DNA fragment encoding the full length Sla2p (T329E,T341E) 
along with promoter cloned in-frame with C-terminal EGFP tag 
and ADH1 terminator into pRS316 vector 
pNB56 DNA fragment encoding Sla2p’s 310-501 amino acids cloned 
in-frame into pGADT7 vector 
pNB60 DNA fragment encoding Sla2p’s 283-580 amino acids with N-
terminal GST tag cloned in-frame into pGEX4T-1 vector 
pNB61 DNA fragment encoding Sla2p’s 283-580 (T329A, T341A) 
amino acids with N-terminal GST tag cloned in-frame into 
pGEX4T-1 vector 
pNB62 DNA fragment encoding Sla2p’s 283-580 (T329E, T341E) 
amino acids with N-terminal GST tag cloned in-frame into 
pGEX4T-1 vector 
pNB70 DNA fragment encoding full length Sla2p along with promoter 
cloned in-frame with C-terminal Myc tag and ADH1 terminator 
into pRS314 vector 
pNB71 DNA fragment encoding the full length Sla2p (T329A,T341A) 
along with promoter cloned in-frame with C-terminal Myc tag 
and ADH1 terminator into pRS304 vector 
pNB72 DNA fragment encoding the full length Sla2p (T329E,T341E) 
along with promoter cloned in-frame with C-terminal Myc tag 
and ADH1 terminator into pRS304 vector 
pNB73 DNA fragment 500 b.p of ABP1 gene along with promoter 
cloned in-frame with C-terminal CFP tag and ADH1 terminator 
into pRS304. Linearized with enzyme Sal1 for integration  
pNB75 DNA fragment encoding Sla2p’s 438-968 amino acids cloned 
in-frame with C-terminal EGFP tag and ADH1 terminator into 
pRS305 vector. Linearized with enzyme Pst1 for integration 
pNB77 DNA fragment encoding Sla2p’s 438-968 amino acids cloned 
in-frame with C-terminal Myc tag and ADH1 terminator into 
pRS304 vector. Linearized with enzyme Pst1 for integration 
pNB78 DNA fragment encoding the full length Sla2p (T329A, T341A) 
along with promoter cloned in-frame with C-terminal Myc tag 
and ADH1 terminator into pRS304 vector. Linearize with 
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enzyme Nhe1 for integration of mutations 
pNB79 DNA fragment encoding the full length Sla2p (T329E, T341E) 
along with promoter cloned in-frame with C-terminal Myc tag 
and ADH1 terminator into pRS304 vector. Linearize with 
enzyme Nhe1 for integration of mutations 
pNB80 DNA fragment encoding 500 bp of ABP1 gene cloned in-frame 
with C-terminal Myc take into pRS306 vector. Linearize with 
enzyme Xba1 for integration 
pNB84 DNA fragment encoding full length Abp1p protein cloned in-
frame into pGBKT7 vector 
pNB85 DNA fragment encoding full length Sla2p protein cloned in-
frame into pGADT7 vector 
pNB86 DNA fragment encoding amino acids 2-359 of Sla2p cloned in-
frame into pGADT7 vector 
pNB87 DNA fragment encoding amino acids 2-359 of Sla2p with 
T329A and T341A mutations cloned in-frame into pGADT7 
vector 
pNB88 DNA fragment encoding amino acids 2-359 of Sla2p with 
T329E and T341E mutations cloned in-frame into pGADT7 
vector 
pNB89 DNA fragment encoding amino acids 310-968 of Sla2p cloned 
in-frame into pGADT7 
pNB90 DNA fragment encoding amino acids 310-968 of Sla2p with 
T329A and T341A mutations cloned in-frame into pGADT7 
vector 
pNB91 DNA fragment encoding amino acids 310-968 of Sla2p with 
T329E and T341E mutations cloned in-frame into pGADT7 
vector 
pNB92 DNA fragment encoding amino acids 2-283 of Sla2p cloned in-
frame with N-terminal GST tag into pGEX4T-1 vector 
pNB94 DNA fragment encoding amino acids 310-580 of Sla2p cloned 
in-frame into pGADT7 vector 
pNB95 DNA fragment encoding amino acids 580-700 of Sla2p cloned 
in-frame into pGADT7 vector 
pNB96 DNA fragment encoding amino acids 580-730 of Sla2p cloned 
in-frame into pGADT7 vector 
pNB97 DNA fragment encoding amino acids 580-930 of Sla2p cloned 
in-frame into pGADT7 vector 
pNB98 DNA fragment encoding amino acids 1-700 of Sla2p along with 
promoter cloned in-frame with C-terminal tag EGFP into 
pRS316 vector 
pNB99 DNA fragment encoding amino acids 1-700 of Sla2p along with 
promoter cloned in-frame with C-terminal tag HA into 
pRSURA3 vector 
pNB104 DNA fragment encoding amino acids 1-700 of Sla2p along with 
promoter cloned in-frame with C-terminal tag Myc into pRS314 
vector 
pNB100 DNA fragment encoding Sla2p with amino acids 700-730 
deleted with promoter cloned in-frame with C-terminal EGFP 
tag cloned into pRS316 vector 
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pNB105 DNA fragment encoding Sla2p with amino acids 700-730 
deleted with promoter cloned in-frame with C-terminal Myc tag 
cloned into pRS316 vector 
pNB137 DNA fragment encoding amino acids 1-730 of Sla2p along with 
promoter cloned in-frame with C-terminal tag HA into pRS316 
vector 
pNB106 DNA fragment encoding amino acids 1-730 of Sla2p along with 
promoter cloned in-frame with C-terminal tag Myc into pRS314 
vector 
pNB138 DNA fragment encoding amino acids 1-768 of Sla2p along with 
promoter cloned in-frame with C-terminal tag EGFP into 
pRS316 vector 
pNB107 DNA fragment encoding amino acids 1-768 of Sla2p along with 
promoter cloned in-frame with C-terminal tag Myc into pRS314 
vector 
pNB139 DNA fragment encoding amino acids 1-930 of Sla2p along with 
promoter cloned in-frame with C-terminal tag EGFP into 
pRS316 vector 
pNB108 DNA fragment encoding amino acids 1-930 of Sla2p along with 
promoter cloned in-frame with C-terminal tag Myc into pRS314 
vector 
pNB109 DNA fragment encoding amino acids 310-580 of Sla2p cloned 
in-frame into pGBKT7 vector 
pNB110 DNA fragment encoding amino acids 580-700 of Sla2p cloned 
in-frame into pGBKT7 vector 
pNB111 DNA fragment encoding amino acids 580-730 of Sla2p cloned 
in-frame into pGBKT7 vector 
pNB112 DNA fragment encoding amino acids 580-930 of Sla2p cloned 
in-frame into pGBKT7 vector 
pNB113 DNA fragment encoding amino acids 2-301 of Scd5p cloned in-
frame into pGADT7 
pNB114 DNA fragment encoding amino acids 302-534 of Scd5p cloned 
in-frame into pGADT7 vector 
pNB115 DNA fragment encoding amino acids 535-872 of Scd5p cloned 
in-frame into pGADT7 vector 
pNB116  DNA fragment encoding amino acids 535-738 of Scd5p cloned 
in-frame into pGADT7 vector 
pNB117 DNA fragment encoding amino acids 739-874 of Scd5p cloned 
in-frame into pGADT7 vector 
pNB118 DNA fragment encoding 1065 b.p of Ark1p cloned in-frame 
with C-terminal EGFP into pRS305 vector. Linearize with 
BamH1 for integration 
pNB122 DNA fragment encoding amino acids 283-580 of Sla2p 
containing mutation T329A cloned in-frame with N-terminal 
GST tag into pGEX4T-1 vector 
pNB123 DNA fragment encoding amino acids 283-580 of Sla2p 
containing mutation T341A cloned in-frame with N-terminal 
GST tag into pGEX4T-1 vector 
pNB101 DNA fragment encoding amino acids 580-700 of Sla2p cloned 
in-frame with N-terminal GST tag into pGEX4T-1 vector 
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pNB102 DNA fragment encoding amino acids 580-730 of Sla2p cloned 
in-frame with N-terminal GST tag into pGEX4T-1 vector 
pNB103 DNA fragment encoding amino acids 580-930 of Sla2p cloned 
in-frame with N-terminal GST tag into pGEX4T-1 vector 
pNB128 DNA fragment encoding amino acids 580-700 of Sla2p with 
amino acids 700-730 deleted cloned in-frame with N-terminal 
GST tag into pGEX4T-1 vector 
pNB135 DNA fragment encoding full length Abp1p along with promoter 
cloned in-frame with C-terminal HA tag into pRS426 vector 
pNB138 DNA encoding last 1000 b.p of Sla1p cloned in-frame with C-





2.1.3 Antibodies and Reagents 
All the chemicals and reagents were purchased from BDH laboratory supplies [UK] 
and Sigma Chemical Company [USA] unless otherwise stated. The components used 
in media preparation were purchased from DIFCO Laboratory [USA] and Sigma 
Chemical Company [USA]. 
           Restriction enzymes and DNA modifying enzymes were from New England 
Biolabs [USA], Amersham [UK], and Boehringer Mannheim [Germany]. 
The antibodies used in this study are from the following sources: 
Antibodies Source 
Rabbit polyclonal anti-HA Y-11 Santa Cruz Biotechnology (USA) 
Mouse monoclonal anti-Myc 9E10 Santa Cruz Biotechnology (USA) 
Mouse monoclonal anti-HA 12CA5 Boehringer Mannheim (Germany) 




HRP-conjugated sheep anti-rabbit IgG Amersham (UK) 
Table 2.3 List of antibodies used in this study 
Table 2.2 List of Plasmids used in this study 
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2.2 Culture conditions 
The E.coli strain DH5a (GIBCO BRL, USA) was used as host strain in this study, for 
DNA recombination and plasmid amplification. The E.coli cells were cultures t 37
o
C 
in LB broth (1% bacto-tryptone, 0.5% bacto-yeast extract, 1% NaCl, pH7.0) or on LB 
agar plates (LB containing 2% bacto-agar). 100μg/ml of Ampicillin (Sigma) or 
50μg/ml of Kanamycin (Sigma) was added to the media to select for E.coli cells 
carrying recombinant plasmids. 
All yeast strains used in this study were derived from the wild-type strain 
W303, except for the strain used in yeast 2-hybrid studies, which was SFY526. Yeast 
cells were grown in standard YEPD media (1.1% yeast extract, 2.2% peptone, 0.006% 
adenine and 2% glucose) or synthetic complete media- SC (0.67% yeast nitrogen base 
without amino acids, 2% glucose and 0.2% appropriate amino acid mix). In order to 
select for and maintain yeast strains containing plasmids with nutritional markers, SC 
media lacking appropriate amino acids was used. For induction of genes controlled by 
the GAL1 promoter, the media was supplemented with 2% raffinose and 2% galactose 
as the carbon source, instead of glucose. SD or YEPD containing agar plates were 
made by adding 2% bacto-agar to the liquid medium. Preparation of all media and 
plates are according to protocols described in Rose et al, 1990.  
Wild-type and non temperature-sensitive cells were grown at 30
o
C while t.s 
cells were cultured at the permissive temperature of 24
o
C and shifted up to 37
o
C for 
analysis of growth and phenotypes at restrictive temperature.  
 
2.3 Recombinant DNA technology 
General recombinant DNA methods were performed essentially as described 
previously (Sambrook, 1990). Polymerase chain reaction (PCR) was performed with 
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Vent DNA polymerase (New England Biolabs, NEB) in conditions recommended by 
the manufacturers. Restriction enzymes (NEB) were used to cut DNA at specific sites 
and digestion was carried out in appropriate buffers and conditions, as recommended 
by the manufacturers. To make blunt-ended DNA fragments, Klenow fragment of 
DNA polymerase (NEB) was used and removal of phosphate on vector was 
performed using calf-intestine phosphate (CIP). T4 DNA ligase (NEB) was used to 
join pieces of DNA.  
2.3.1 DNA transformation of E.coli cells 
Foreign plasmid DNA was introduced into competent E.coli cells in the 3 following 
ways.  
Heat-shock method: 100μl of heat-shock competent cells were allowed to mix 
with ~10μl of ligation mix or >0.1μg of intact plasmid, for 30-45 minutes on ice. The 
cell-DNA mixture was then subjected to a heat shock for 50s at 42
o
C, and then on ice 
for 1 minute. The cells were then allowed to recover for 1.5h at 37
o
C in LB medium 
before plating on LB agar plates containing antibiotic for selection. 
Chemical transformation: Ligation product was first mixed with 100μl of 
KCM solution (100mM KCl, 30mM CaCl2, 50mM MgCl2) then mixed with 100μl of 
competent E.coli cells and subjected to the same protocol as mentioned above. 
Electroporation transformation: was carried out by mixing DNA with 50μl of 
competent cells followed by passage of high voltage using Gene Pulser (Bio-Rad) 
according to manufacturers instructions. The cells were recovered at 37
o
C, in LB for 
1.5h and then plated on antibiotic containing selection plates. 
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2.3.2 Plasmid DNA preparation 
Overnight bacterial cultures (2ml) were pelleted by centrifugation at 13krpm for 30s 
and the resulting pellet was treated with various solutions of the Qiaprep spin 
Miniprep Kit (Qiagen). 
2.3.3 Site-directed mutagenesis 
The in vitro site-directed mutagenesis was performed using overlap extension PCR 
technique illustrated in Fig. 2-1 (Ho et al., 1989). Two complementary primers [MF 
and MR] were synthesized where the intended mutational sequences were ideally 
located in the middle. Two rounds of PCR gave rise to the mutant PCR product, and it 
was then cloned into appropriate vectors and verified by DNA sequencing. The same 
strategy and/or slight modification were employed to create all the sequence 
substitution and gene truncations.  
In order to mutate threonines at positions 329 and 341 to either alanines or 
glutamines, the following mutagenesis primers were designed:  
TA forward: 5’-CAA ACT ATG CCG GCG GGT GCC ACC ACT GGG ATG 
ATG ATC CCC ACT GCC GCT GGT GCA CGT-3’ 
TA reverse: 5’-ACG TGC ACC AGC GGC AGT GGG GAT CAT CAT CCC 
AGT GGT GGC ACC CGC CGG CAT AGT TTG-3’ 
TE forward: 5’-CAA ACT ATG CCG GAG GGT GCC ACC ACT GGG ATG 
ATG ATC CCC ACT GCC GAG GGT GCA CGT-3’ 
TE reverse: 5’-ACG TGC ACC CTC GGC AGT GGG GAT CAT CAT CCC AGT 
GGT GGC ACC CTC CGG CAT AGT TTG-3’ 
These primers were used to generate double mutations either to alanine or glutamine. 
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Figure 2.1 Schematic of site directed mutagenesis 
 
 
2.4 Yeast Genetic Manipulations 
Yeast genetic techniques were performed according to standard methods described in 
Rose et al, (1990). 
2.4.1 Yeast transformation and integration 
The host cells were grown in appropriate medium to log phase and pelleted by 
centrifugation at 3Krpm for 5 minutes. About 50μl of cell pellet was washed with 
water to remove leftover media and resuspended in 100μl of transformation mix (10μl 
of 2M LiAc, 80μl of 50% PEG8000 and 10μl of 1M DTT). Plasmid DNA and ~5μl of 
denatured Salmon sperm DNA (9.5μg/μl, Sigma) was thoroughly mixed with the 
CHAPTER II MATERIALS & METHODS 
57 
above cell suspension and incubated at 42
o
C for 30 minutes. The cells were harvested 
by centrifugation and resuspended in 1ml of H2O. They were then evenly spread on 
plates containing selective media and allowed to grow at appropriate temperature for 
3-4 days.  
2.4.2 Gene disruptions and manipulation 
Gene disruptions were performed by the single step gene replacement method 
(Rothstein, 1991). To disrupt SLA2, the HIS3 gene replaced the portion of the gene 
between restriction sites PshA1 and EcoRV in order to generate the deletion cassette 
(plasmid pNB29). For gene integration, the plasmid pNB29 was linearized within the 
SLA2 gene by SacII digestion and transformed into W303-1A and W303-1B to 
generate the strains YNB40 and YNB41. Deletion of SLA2 was confirmed with whole 
cell PCR. 
 
2.5 Yeast Cell Biology Protocols 
2.5.1 Yeast two-hybrid assay 
MATCHMAKER system (Clontech Laboratories, USA) was used to conduct yeast 2-
hybrid experiments. DNA fragments of SLA2 was fused, in frame, to the GAL4 
activation domain in the vector pGADT7 and fragment of SCD5 was fused to the 
DNA binding domain of pGBKT7 (see table X). The plasmids were transformed into 
SFY526 and -galactosidase activity was measured of at least three different isolates 
of every transformation. The -galactosidase activity assay is mentioned in the 
product protocol (http://www.clontech.com/images/pt/PT3024-1.pdf). 
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2.5.2 Endocytosis assays 
 2.5.2.1 Lucifer Yellow uptake 
Cells were grown, overnight in selective media at the appropriate temperature up to 
O.D of >0.5. In order to see effect of temperature upon uptake, cells were diluted in 
fresh media was allowed to grow back to OD of 0.5 at the higher temperature. 1ml of 
culture was placed in a 1.5ml microfuge tube, whose lid had been perforated, and 
cells were harvested by spinning gently at 3Krpm for 1 minute. The supernatant was 
discarded and the pellet was resuspended in 90μl of SD media. To this, 10μl of 
50mg/ml Lucifer yellow (LY,) stock was added and the cells were aerated by flicking 
the tube several times. The tubes were incubated at appropriate temperature for 1-2 
hours. 1ml of ice-cold stop mix (50mM Na2HPO4/NaH2PO4 buffer, 10mM NaF, 
10mM NaN3, pH7.0) was added in order to stop the assay. Cells were pelleted by 
gentle centrifugation at 3Krpm for 2 minutes and washed three times with ice-cold 
stop mix to remove excess dye. Cells were resuspended in 10μl of mounting media 
and visualized under microscope. 
2.5.2.2 FM4-64 uptake and pulse-chase assay 
For simple uptake of the dye FM4-64, cells were first grown overnight at the 
appropriate temperature to OD600 of about 0.5. 10μl of FM4-64 stock (2mg/ml, 
dissolved in DMSO. Source of FM4-64: Molecular Probes, USA) was added to 
achieve final concentration of 2mM and allowed to incubate for 1 hour at appropriate 
temperature. Cells were then harvested by centrifugation at 3Krpm for 2 minutes and 
washed twice with ice-cold media. 10μl of mounting media was added to the cells and 
then visualized under microscope. 
 Progress of endocytosis from the plasma membrane to the vacuole was tracked 
using a pulse-chase method, modified from Vida and Emr (1995). Cells were again 
CHAPTER II MATERIALS & METHODS 
59 
grown to OD600 >0.5 and were harvested by centrifugation. The cell pellet was 
resuspended in ice-cold SD medium and FM4-64 was added to a final concentration 
of 2mM. The tube was allowed to incubate on ice for 20 minutes. A sample of cells 
marking t=0 was taken out from the tube and membrane transport was blocked using 
stop mix. The remaining cells were spun down gently and washed with ice-cold 
media to remove excess dye. The pellet was then resuspended in pre-warmed media 
and incubated at the appropriate temperature. Aliquots were taken at time-points of 5, 
10, 15 and 30 minutes. Each aliquot was washed twice with stop mix to prevent 
further endocytic events.  The progress of the dye was visualized using the TRITC 
filter in the fluorescent microscope. 
2.5.2.3 Fur4p uptake assay 
 Test strains were first transformed with an episomal plasmid containing the FUR4 
gene. Cells were grown in SD medium containing appropriate amino acids, till they 
reached OD600 of 0.5. Internalization of permease at various temperatures was 
assayed after the addition of cycloheximide (100μg/μl) which stops further protein 
synthesis. 1ml of culture at every time point, post-cycloheximide treatment, was 
incubated in 10μl of 14C-uracil solution [450μl of 1mM cold uracil + 50μl of labeled 
uracil (NEN)] for 20s at test temperature. The mixture then was quickly filtered 
through filters (Whatman GF/C filters), which were flushed twice with 5ml of ice-
cold water to remove excess of labeled uracil. The filters were carefully lifted and 
placed in scintillation fluid and counted in a scintillation counter. Percentage uptake 
was calculated by dividing values at various time points with the value corresponding 
to t=0 and a graph showing the trend was plotted. 
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2.5.3 Drop test 
Cells were grown overnight iin appropriate media, to OD600 of 0.5. Cells were 
diluted 10 times, 100 times or 1000 times. 10μl of each diluent was taken with a 
pipette and accurately dropped on an YPD or SD plate. The plates were allowed to 
dry for 30 minutes before covered and wrapped in parafilm and placed in an incubator 
of appropriate test temperature. The size of the colonies were measured and compared 
after 3 days. 
 
2.6 Fluorescent microscopy 
2.6.1 Fixing and staining with rhodamine phalloidin 
Staining of actin filaments with rhodamine-phalloidin [Molecular Probes, Eugene, 
OR] was performed as described previously (Adams & Pringle, 1991) with minor 
modifications. Cells were grown at 25 C in YEPD to early log phase and then kept at 
25 C or shifted to 37 C. After incubation for 4 h, cells were colleted and suspended 
in fixation solution [3.7% formaldehyde, 100mM KH2PO4, 100mM K2HPO4] for 15 
min. Cells were then washed two times with PBS and resuspended in PBS containing 
0.1% Triton X-100 for 15 min. After washing again with PBS for two times, cells 
were incubated with PBS containing rhodamine-phalloidin [1:100] at 25 C for 30 
min. Cells were finally washed with PBS for four times and suspended in Vectashield 
mounting medium before visualization with the Leica DMAXA microscope. 
2.6.1 Live-cell, time lapse microscopy 
Yeast cells expressing GFP and/or CFP tagged proteins were allowed to grow to early 
log phase at 30°C. Cells
 
were harvested, resuspended in SC media, and adhered to the 
surface of an agarose [2 %] coated glass slide, which was covered with a coverslip 
and sealed with vaseline. Fluorescence microscopy was performed
 
using a Zeiss 
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Axiovert 200 M microscope equipped with
 
a Coolsnap HQ camera [Roper Scientific, 
Tucson, AZ]. All imaging was done by keeping the slide within a closed chamber 
maintained at requisite temperature- 25
o
C, 30°C or 37
o
C.  Images were acquired 
continuously at 1 frame/ 1-2.5 s, with motorized GFP and CFP filters. The CCD 
camera and the filter wheel were controlled by MetaMorph software [Universal 
Imaging, Downingtown,
 
PA].  To determine the patch lifetime of each protein, more 
than 30 patches were visually analyzed for their time points of appearance and 
disappearance. 
2.7 Protein Analysis 
2.7.1 Crude yeast protein extract 
Preparing crude lysate for immunoprecipitation: 
Yeast strains were grown in appropriate conditions to mid-log phase (OD600 = 0.9 to 
1.2). Cells were harvested, washed once with stop-mix buffer (0.9%NaCl, 1mM 
NaN3, 10mM EDTA, 50mM NaF) and resuspended in 200 μl of ice-cold lysis buffer 
[1% Triton X-100, 0.1% SDS, 100mM NaCl, 50mM Tris-HCl [pH7.2], 1mM PMSF, 
20μg/ml leupeptin, 40μg/ml aprotinin, 0.1mM Na-orthovanadate, 15mM p-
nitrophenyl phosphate (PNPP)]. 200μl of acid-washed 500μm-diameter glass beads 
(Sigma) were added to the cell suspension and the cells were lysed by vortexing 
vigorously using Microsmash (Japan). After two rounds of high-speed centrifugation 
to pellet out the cellular debris, the supernatant containing the crude cell lysate was 
collected, snap frozen in liquid nitrogen and stored at -80°C. Protein concentration 
was determined using the Coomassie Plus-200 Protein Assay Reagent (PIERCE, 
U.S.A). Crude protein extraction prepared by this way can be used for 
immunoprecipitation. 
Preparation of total protein extracts using TCA precipitation 
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      Cells equivalent to OD600=4 were harvested by centrifugation and resuspended in 
300μl of ice-cold water.  Then, 150μl of YEX lysis buffer (1.85M NaOH, 7.5% -
mercaptoethanol) was added and the suspension was kept on ice for 10 min.  
Subsequently, 150μl of 50% ice-cold TCA was added to the suspension which was 
further kept on ice for another 10 min.  The precipitate was collected by 
centrifugation at 4°C for 5 min and then resuspended in a solution containing 100μl of 
SDS-loading buffer (100mM dithiothreitol, 50mM Tris-HCl [pH 6.8], 2% SDS, 0.1% 
bromophenol blue, 10% glycerol) and 15μl 1M Tris buffer [pH 8.0].  The preparation 
is ready for loading on an SDS-PAGE after boiling for 10 min.   
2.7.2 Immunoprecipitation and western blot 
About 800μl of crude cell lysate prepared using acid- washed glass beads described in 
2.7.1 was added to 15μl of sepharose beads conjugated to polyclonal antibodies which 
recognized either HA or Myc epitope tags (Santa Cruz Biotechnologies, Santa Cruz, 
USA). This mixture was allowed to incubate on a roller at 4
o
C for 1 hour. The beads 
were then washed 4 times in RIPA buffer (1% Triton X-100, 150mM-750mM NaCl, 
50mM Tris-HCl, pH 7.2) supplemented with protease inhibitors to stop protein 
degradation. The concentration of NaCl was increased in cases where a lot of non-
specific binding was observed. The proteins bound to immuno-beads were released by 
boiling for 10 minutes in SDS loading buffer and resolved by SDS-PAGE. 
 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
according to standard protocols (Sambrook et al., 1989) using the Mini-PROTEIN II 
electrophoresis cell (Bio-Rad, USA). The separation gel contained 8% to 12% of 
acrylamide mix (acrylamide:bisacrylamide, 29:1), 375mM Tris-HCI [pH8.8] and 
0.1% SDS. The stacking gel contained 5% acrylamide mix, 125mM Tris-HCl [pH6.8] 
and 0.1% SDS. Polymerization was induced by the addition of TEMED and freshly 
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prepared ammonium persulfate. Protein samples in SDS-loading buffer were boiled 
for 8 min, and loaded onto the gel. The electrophoresis was carried out in Tris-glycine 
buffer (25 mM Tris, 250 mM glycine, 0.1% SDS). The rainbow colored high 
molecular weight protein marker (Amersham) or the pre-stained broad range protein 
marker (New England Biolabs) was used to estimate the size of proteins. 
 After electrophoresis, the separated proteins were electro-transferred onto 
Immobilon PVDF membranes (Millipore, USA) using the liquid transfer cell (Bio-
Rad, USA). The transfer buffer contained 3.30g/L Tris and 14.4g/L glycine. For 
immuno-detection (Western blot), the membrane was incubated overnight at 4°C in 
blocking solution (PBS containing 0.05% Tween-20 and 5% skimmed milk). The 
membrane was then incubated with the primary antibody followed by the HRP-
conjugated secondary antibody. Each incubation lasted for 1 h at 24°C, followed by 
extensive wash with PBS containing 0.05% Tween-20. The antibody-antigen 
complexes were visualized with the Enhanced Chemiluminescence (ECL) system 
(Amersham, UK). 
2.7.3 Purification of GST- and His-tagged proteins and in 
vitro binding assays 
To make GST-fusion proteins, DNA fragments were generated by PCR and cloned in-
frame into the bacterial GST expression vector pGEX-4T-1 as indicated in Table X. 
The plasmids were then transformed into the E.coli strain BL21 and transformants 
were grown in 400ml of ampicillin supplemented LB medium to OD600=0.5.  Protein 
synthesis was induced by addition of IPTG (final concentration: 1mM) and allowed to 
shake at 37oC for 4 hours. The cells were harvested by centrifugation and resuspended 
in 5ml of ice-cold PBS. The cell suspensions were sonicated for 1 minute and then 
spun down at high speed for 10 minutes. The supernatants were incubated with 
Glutathione Sepharose 4B beads (Pharmacia) for 1 hour at 4oC and then washed thrice 
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with PBS. The fusion protein was eluted by incubation with elution buffer (10mM 
glutathione, 50mM Tris-HCl, pH8.0) for 10 minutes, the process repeated three times 
(Zeng and Cai, 1999). Using VIVASPIN 500 columns (Vivascience, Hannover, 
Germany), GST-fusion proteins were washed and buffer exchanged into either 
binding buffer (100mM NaCl, 20mM HEPES, pH 7.3, 0.1% Triton X-100, and 1mM 
dithiothreitol [DTT]) for in vitro binding assay or H2O for protein phosphatase assay 
(Zeng et al, 2007).  
 To make His-tagged protein, DNA fragments were generated by PCR and 
cloned into pET-32a to fuse with an N-terminal His-epitope as described in Zeng et 
al, 2007. The plasmids were transformed into bacterial strain BL21. Transformants 
were grown to OD600=1.0 and incubated with 1mM isopropylthio--d-galactoside 
(IPTG) at 37°C overnight. Cells were collected by centrifugation and suspended in 
cold extraction buffer (1% Triton, 150mM NaCl, 5mM imidazole, 20mM Tris-HCl, 
pH 8.0, and 1mM PMSF). The suspensions were sonicated on ice, and lysates were 
centrifuged at 17,000 rpm for 20 min. The supernatants were incubated with 
prewashed nickel-nitrilotriacetic acid agarose beads (QIAGEN, Valencia, CA) for 1 
hour at 4°C. After wash with washing buffer (200mM NaCl, 20mM HEPES, pH 7.3, 
0.1% Triton X-100, and 1mM DTT) three times, the beads were incubated with GST-
fusion proteins in 500 l of binding buffer for 1 h at 4°C. The bead-bound proteins 
were washed with washing buffer five times and subjected to gel electrophoresis and 
sequential immunoblotting with anti-GST and anti-His antibodies. 
2.7.4 GST pull down assay 
Yeast extracts were incubated with 50μl of beads-bound GST-fusion proteins for 2 
hours at 4
o
C. The beads were then washed 4 times with RIPA buffer and the bound 
proteins were released by boiling in SDS loading buffer at 100
o
C for 5 minutes. After 
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centrifugation, samples were loaded onto a SDS-polyacrylamids gel for 
electrophoresis. The separated proteins were then electro-blotted onto PVDF 
membranes as described earlier and probed with appropriate antibodies. 
2.7.5 In vitro kinase assay 
Yeast extracts containing HA-tagged Prk1p were incubated with rabbit polyclonal 
anti-HA antibody conjugated with sepharose beads (Santa Cruz Biotechnologies) for 
1 hour at 4
o
C. The beads were first washed twice with RIPA buffer and then once 
with 25mM MOPS (pH7.2) buffer. Finally, the beads were resuspended in 6μl of 
HBII buffer (60mM b-glcerophosphate, 25mM MOPS, 15mM PNPP, 15mM MgCl2, 
5mM EGTA, 1mM DTT, 1mM PMSF, 20μg/ml leupeptin, 0.1mM sodium ortho-
vanadate). To this prepapration of kinase/beads, 5μg of GST-fusion proteins, 0.5μl of 
1mM ATP and 1μl of 250mM MOPS were added and made up to a total volume of 
20μl. The reaction mix was allowed to incubate at 25oC for 1 hour and the kinase 
reaction was stopped by addition of SDS loading buffer and boiling at 100
o
C for 5 
minutes. The mix was spun down and loaded onto an SDS-polyacrylamide gel and the 
immuno-blot was probed sequentially with anti-PThr and anti-GST antibodies to 
visualize level of phosphorylation. 
2.7.6 In vitro phosphatase assay  
For in vitro protein phosphatase assays, yeast extracts containing endogenously 
expressed Glc7-HA were prepared with phosphatase inhibitor-free lysis buffer (1% 
Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50mM Tris-HCl, pH 7.2, and 
1mM phenylmethylsulfonyl fluoride [PMSF]) supplemented with protease inhibitors 
(cocktail tablets from Roche Applied Science). Glc7-HA was immunoprecipitated and 
washed with RIPA buffer (50mM Tris-HCl, pH 7.2, 150mM NaCl, 1% Triton X-100, 
1% sodium deoxycholate, and 0.1% SDS) five times. The immuno-precipitates, with 
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or without pre-incubation with 1μl of PP1 inhibitor I-2 (New England Biolabs, 
Ipswich, MA) at 25°C for 15 min, were mixed with phosphorylated GST-fusion 
proteins and 10μl of 10X PP1 buffer (New England Biolabs) in a total volume of 
100μl. The mixture was incubated at 37°C, and 20μl of supernatant was taken at each 
time point in 20-min intervals. Samples were then subjected to gel electrophoresis and 
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3.1 BACKGROUND 
Sla2p, a multi-domain protein, is vital for both endocytosis as well as 
maintaining regulating actin polymerization at the cortex. Previous studies in our lab 
had hinted at the possibility that Sla2p could potentially be a substrate of Prk1p, a 
kinase important for actin regulation in S.cerevisiae. Prk1p kinase is an actin 
regulatory kinase, which is known to predominantly phosphorylate proteins involved 
in regulation of the actin cytoskeleton and endocytosis. Amongst its substrates are 
Sla1p, Pan1p, Scd5p and Ent1/2p as well as a plethora of other unconfirmed putative 
targets, almost of which are involved in trafficking pathways at the plasma 
membrane, Golgi, ER etc.  Sla2p is a key node in this interaction network via its 
interactions with Sla1p, Pan1 as well as Scd5p - proteins whose functions are 
modified by Prk1p. Hence I was interested in studying the regulation of Sla2p and its 
function by a similar process.  
Conversely, dephosphorylation of certain targets of Prk1p, namely Pan1 and 
Scd5p, have been shown to be vital in replenishing the pool of unphosphorylated 
protein (Zeng et al, 2007). Glc7p, a protein phosphatase 1, was shown to bind to its 
regulatory subunit Scd5p, which targeted it to the cortical actin patches and sites of 
active endocytosis (Zeng et al, 2007). Sla2p had been shown to bind to Scd5p (this 
study; Henry et al, 2002) and I was interested in further dissecting this interaction. 
Based on the model proposed by Zeng et al, I was keen to establish a similar pattern 
of dephosphorylation and phosphorylation cycle for Sla2p at the cell cortex.   
In this chapter I sought out to answer the questions: is Sla2p a phospho-protein 
in vivo and do the members of Ark1p/Prk1p family of kinases specifically 
phosphorylate it? If so, what would the physiological consequences of this 
modification be? How would phosphorylation affect the activity of Sla2p and its 
binding partners? Does Sla2p undergo a dephosphorylation step similar to other 
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proteins in the endocytic coat complex? Answering these questions would 
undoubtedly shed light on the mechanism of function of this protein, which while 
being vital for endocytosis, very little is known about its actual function and 
regulation. 
3.2 Sla2p is a substrate of Prk1p kinase 
3.2.1 Identification of Prk1p phosphorylation through protein 
sequence analysis 
Previously identified substrates of Prk1p kinase contain multiple copies of distinct 
consensus motifs that the kinase recognizes, binds to and phosphorylates the 
conserved threonine in the motif. Many actin regulatory proteins contain multiple 
Prk1p phosphorylation sites. Prk1p motifs are very distinct and are usually of the 
form [L/I/V/M]xx[Q/N/T/S]xTG (Huang et al, 2003; Zeng and Cai, 1999), where x 
represents any amino acid. The threonine (T) present is the phosphorylable motif 
(denoted as P) and the presence of the glycine (G) residue (denoted as P+1) just C-
terminal of it, are absolutely necessary for the kinase to bind and phosphorylate. P-5 
position (i.e. amino acid moiety present 5 amino acids N-terminal from 
phosphorylable threonine P) usually requires a bulky hydrophobic residue for 
efficient recognition and phosphorylation by Prk1p, while the P-2 position can be 
either Q, N, T or S but the restriction at this site is less stringent (Huang et al, 2004). 
Using pattern mapping I identified 2 consensus sites (Figure 3.1A) in Sla2p, which 
are found clustered just N-terminal of the central large coiled-coil domain. These sites 
are of the sequence LQTMPTG (a.a 324-330) and MIPTATG (a.a 335-342).
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3.2.2 Sla2p is a substrate of Prk1p in vitro 
In order to demonstrate that Sla2p is a substrate of Prk1p, I performed the in vitro 
kinase assay as described in section 2.7.5.  A fragment of Sla2p (amino acids 311 to 
580), which contains both putative phosphorylation sites as well as the complete 
central coiled-coil domain, was expressed as GST-fusion protein. The consensus 
threonine moieties at positions 329 and 341 were mutated to alanine, singly (TA or 
AT) or doubly (AA) and were subjected to the kinase reaction for 1 hour. Figure 3.1B 
shows that the wild-type fragment is strongly phosphorylated by wild-type Prk1p and 
not by kinase-dead (D158Y mutation) Prk1p (Lanes 3 and 4). Mutation of both 
threonine residues to alanine completely abrogates phosphorylation while either 
single mutation renders the level of phosphorylation to approximately half. These 
significant results seem to indicate that Prk1p specifically phosphorylates Sla2p on 
threonine residues at positions 329 and 341. 
3.2.3 Sla2p is a phosphorylated protein in vivo and is likely 
to be exclusively phosphorylated by the Ark1/Prk1 family 
of kinases 
In vitro kinase assays showed Sla2p to be a bona fide target of Prk1p phosphorylation 
but its physiological context was not known. For physiological relevance of this post-
translational modification, it was important to find out if Prk1p phosphorylated Sla2p 
in the cell. Immunoprecipitated Sla2p was separated on a SDS-PAGE gel and 
subjected to western blot using polyclonal anti-phosphothreonine antibodies as 
described in Chapter 2. HA-tag was added to the Sla2p-C terminus in the genome 
through targeted modification. In a wild-type background, Sla2p appears as a strongly 
phosphorylated band of ~150KDa with a corresponding epitope-tagged signal at the 
same site. The protein runs at a size slightly higher than the predicted size of 120KDa. 
A mutant strain that lacks the Prk1p kinase (prk1) shows a marked decrease in 
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phosphorylation (~50%, Fig 3.1D Lane 3) while ark1 cells show almost wild type 
levels. Deletion of both kinases almost completely abrogated phosphorylation in 
Sla2p, as exhibited by the double deletion strain ark1 prk1 (Figure 3.1D, lane 4). 
 
3.3 Phosphorylation of Sla2p affects its function at the cell 
cortex 
Having established Sla2p as a bona fide target of Prk1p, and to a lesser extent, of 
Ark1p kinase, I wished to determine how the phosphorylation of Sla2p regulated its 
function in the cell. Sla2p is a multi-domain protein that mediates various protein-
protein interactions and functions at the cusp of endocytosis and actin polymerization. 
I examined the effects of this phosphorylation on various aspects of the protein known 
to be important for function, namely localization, cortical dynamics, protein-protein 
interaction and also the effects in important cellular processes such as actin 
organization and endocytosis. 
3.3.1 Localization and patch dynamics of Sla2p is affected by 
phosphorylation 
Sla2p localizes to distinct punctae at the cell cortex (Wesp et al, 1997, Holtzmann et 
al, 1993). The protein is membrane associated but not a transmembrane protein (data 
not shown). The localization pattern of Sla2p closely follows that of actin patches and 
other endocytic and actin-regulatory proteins such as Abp1p, Sla1p and Pan1p and 
partially overlaps with them (Kaksonen et al, 2002). The phosphorylation mutants 
were created using site-directed mutagenesis as described in Chapter 2. Mutating 
conserved threonines to alanines mimicked the unphosphorylated states (T329A 
T341A, denoted as Sla2AAp). Mutating the same residues to glutamine (T329E 
T341E, denoted as Sla2EEp) provided with a phoshpo-mimetic form of the protein 
as due to the persistent negative charge afforded by the acidic glutamine residues 
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mimics the negative charge of the phosphate residue. I used these constructs, 
expressed ectopically in sla2 cells, under the control of the SLA2 promoter. In order 
to visualize the protein, C-terminal EGFP tags were added. In still images of fixed 
cells that are also stained with the actin dye- rhodamin phalloidin, Sla2p appears as 
dots near the cortex as published, with similar distribution as actin (Figure 3.3A, B, C 
and Holtzmann et al, 1993) but some dots clearly visible in the mother cell. The 




p show localizations that are virtually 
identical to that of the wild type protein (Figure 3.3A, panels 1-3). I then decided to 
look at the dynamics of the protein at the cells cortex. Kaksonen et al in 2004, 
showed, using live-cell time lapse microscopy, that actin patches as well as cortical, 
endocytic proteins form highly motile structures. These proteins appear and disappear 
from the cortex in a tightly choreographed manner. Most endocytic coat proteins 
show similar behavior and may vary only in sequence and duration at the cell surface. 
Sla2p was shown to have a lifespan of about 35s, during which a spot containing the 
protein arrives and steadily grows stronger in signal, then moves slowly away, 
laterally, from the initial point of formation and later moves ~200nm into the interior 
of the cell, and dissociates, after which no signal can be detected at the surface. Using 
similar technique as described in literature (Kaksonen et al, 2003) I tried to visualize 
whether phosphorylation played a role in modulating the dynamics of Sla2p. My 
observation of more than 50 patches showed wild-type Sla2p of having a lifespan of 
about ~33.5 seconds. The imaging protocol used 2-dimensional, epi-fluorescent 
microscopy, which is not able to deconvolute internal signals. The definition of a 
protein’s “lifespan” at the cortex is therefore defined as the period of time during 
which a protein begins to assemble as a dot on the surface, becomes brighter and 
eventually fades away and cannot be differentiated from the background. The 
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disappearance of the patch from the cortex can be either due to disassembly of the 
protein from the surface or its movement away from the periphery. This change can 
only be differentiated by following the protein movement in 3D over time. Prior 
studies by Drubin’s lab had established the movement of cortical patch components 
and the trajectories of Sla2p, Abp1p, Sla1p, Pan1p and Ark1p are known. While 
confocal microscopy is able to visualize internal signal, 2D fluorescent microscopy 
afforded better resolution as well as lesser photo-bleaching, allowing us to view even 
the fainter patches over the course of their entire lifespan at the cortex. Interestingly, 
the phospho-mimetic mutant, Sla2
EE
p showed a significantly prolonged lifespan of 40 
(+5) seconds  (Fig 3.3C, etc) compared to wild type (34+5s) while the 
unphosphorylated mutant, Sla2
AA
p showed almost identical lifespan to that of wild 
type (30+4s). The difference in mean lifespans between wild-type and Sla2
EE
p is 
statistically significant at 5% confidence levels. 
3.3.2 Localization and patch dynamics of other endocytic 
proteins are affected by phosphorylation of Sla2p 
Sla2p functions at the cell cortex as a protein that provides a crucial link between the 
endocytic machinery and the actin polymerization machinery. Through it’s multi-
modal secondary structure, it is able to bind other proteins such as Sla1p (Gourlay et 
al, 2003), Pan1p (Toshima et al, 2007), clathrin (Henry et al, 2002)), actin filaments 
(Yang et al, 1998), phospho-inositols (Sun et al, 2004) etc. Since all these proteins’ 
dynamics are tightly coupled with each other, I was curious to find out if 
phosphorylation of Sla2p by Prk1p would affect lifespan of Sla2p’s binding partners. 
I tagged the proteins with either C-terminal GFP (in the case of Sla1p, Ark1p, Pan1p) 
or RFP (Abp1p) by methods described in Chapter 2. These tagged proteins were 




p as the 
sole source of the protein (YNB13, 14 and 15).  
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Abp1p is tightly associated with cortical actin patches and is used as marker 
for actin patches. Sla2p shows a partial overlap with Abp1p patches in still images 
(data not shown). Sla2p appears early in the endocytic process and is joined by an 
Abp1p-containing patch and they persist together for ~12 seconds before disappearing 
from the surface. The loss of Abp1p signal from the cell surface is thought to coincide 
with the downward movement of the vesicle, which is preceded by a burst of actin 
polymerization (Kaksonen et al, 2004). Using similar techniques described earlier, I 
studied the lifespan of Abp1p-RFP in the three phospho-alleles of Sla2p. In cells 
expressing Sla2
AA
p, Abp1-RFP appeared to have a slightly reduced lifespan 
compared to that in wild-type cells (9+2.8 seconds as compared to ~12 seconds, 
figure 3.2). Conversely, in sla2
EE
 cells I observed that Abp1p lingered at the cell 
cortex longer than in wild type cells (lifespan ~15.2s+3.2s). The difference in means 
of Abp1p lifespans of wild-type and are statistically significant at 95% confidence 
levels. 





 strains. Sla1p and Sla2p have similar localization patterns and show 
similar lifespan and dynamics at the cortex. Sla1p appears slightly before Sla2p in the 
initiation of endocytic coat formation. Sla2p and Sla1p have been shown to physically 
interact and Sla1p is important for the cortical localization of Sla2p (Gourlay et al, 





, the lifespan reflected that of wild-type (Figure 3.5 A, B and C). Cells 
in which Abp1-RFP and Sla1-GFP are co-expressed showed lifespan of each protein 
to be identical to the singly tagged strains (data not shown). 
The next protein I examined was Pan1, which was recently shown to interact 
with Sla2p (Toshima et al, 2007). Sla2p was shown to negatively regulate Pan1p’s 
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ability to activate the Arp2/3 complex by shielding the actin-binding site on Pan1p. I 
was curious to find out whether the phosphorylation status of Sla2p would affect the 
dynamics of Pan1p in the cortex as observed in the cases of Abp1p and Sla1p. Pan1p 
was fused with a C-terminal GFP tag and integrated in the above strains. I found that 
Pan1p was more significantly affected by phosphorylation on Sla2p. In the sla2
EE
 
strain Pan1p’s life span was increased by almost 50% (38.5+6.1s, compared with 
25.5s in WT) while sla2
AA
 mutant did not affect the dynamics of Pan1 (28.5s). The 
difference in Pan1p lifespans between wild-type and sla2
EE
 is statistically significant 
at 95% confidence level. Pan1p, thus far, showed the most dramatic increase in 
lifespan upon phosphorylation of Sla2p (figure 3.6A,C). 
Ark1p has been shown to bind to Sla2p (Cope et al, 1999; Figure 3.7) and also 
phosphorylate it in the absence of Prk1p (Figure 3.1D). Dynamics of Ark1p was not 
much affected by the phosphorylation state of Sla2p (Fig 3.7C), as Ark1p showed a 
cortical lifespan of ~13-15s which was not significantly different from one another. 
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3.3.3 Sla2p phospho-status affects receptor-mediated but not 
fluid-phase endocytosis 
In order to pinpoint how the phosphorylation of Sla2p affects its function in 
pertinent processes, I decided to study endocytosis in the phosphorylation mutants. 
Sla2p was first discovered in a genetic screen for endocytosis mutants (Raths et al, 
1993). SLA2 null mutant is severely defective in all forms of endocytosis even at 
temperatures permissive for growth (Holtzmann et al, 1993, Wesp et al, 1997). I 
decided to look at three different aspects of endocytosis using three different assays: 
Lucifer yellow uptake, which demonstrates fluid-phase endocytosis, FM4-64 pulse-
chase assay which tracks membrane turnover and finally Fur4 uptake, which 
quantitatively measures the uptake of receptors from the cell membranes (Chapter 2 
for detailed description and experimental conditions).  
Figure 3.8A (panels 1-5) shows the uptake of the water-soluble dye Lucifer 
yellow (LY) in wild type and sla2 mutant. After 1 hour at either 25oC or 37oC, wild-
type (W303) cells show intense vacuolar staining while virtually no dye is seen 
staining the membrane. In stark contrast, the sla2 cells show almost no vacuolar 
signal but the bulk of the dye appears to have accumulated at the surface, unable to 




p, expressed as the sole source of Sla2p in 
sla2 cells, were able to fully restore uptake of LY from the outside of the cell to the 
vacuole. There appeared to be no discernible difference in either mutant’s ability to 
take up the dye.  
The second parameter I studied was receptor- mediated endocytosis (RME). In 
this assay, I tracked the inward movement of the uracil receptor Fur4p upon binding 
to its cargo: H3-labeled uracil. Fur4p is a uracil permease that binds to its cargo 
(uracil) and gets internalized to the vacuole in an energy dependant process. The 
assay measures the percentage of permease remaining on the cell surface, over time, 
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after addition of cycloheximide to block protein synthesis. In wild type cells, half-life 
of this assay is about 35 minutes (Figure 3.8B.) but the sla2 cells barely are able to 
internalize 20% of the cargo in the time frame. Interestingly, Sla2
EE
p cells 
consistently showed a significant delay in taking up the receptor but Sla2
AA
p showed 
a kinetic which is very similar to that of wild type. Thus the phosphorylation status of 
Sla2p appears to play a measurable role in quantitative RME but not fluid-phase 
endocytosis or membrane turnover. 
 
3.3.4 Sla2p’s phosphorylation affects its interaction with 
some of interacting partners but not others 
Sla2p’s phosphorylation status played an important role in regulating its kinetics as 
well as function in RME. I next hypothesized that phenotypes could be explained, in 
part, by modulation of protein-protein interaction by this post-translational 
modification. I looked at interactions with several of Sla2p’s known binding partners 
such as Sla1p, clathrin light chain, Pan1p, Sla2p (Wesp et al, 1997), Ark1p and Scd5p 
(Henry et al, 2005). The phosphorylation sites (T329 and T341) lie just upstream of 
the first coiled-coil domain of Sla2p (Figure 3.1A) and could play a role in 
modulating the various interactions mediated by this domain, including dimerization.  
Using quantitative yeast 2hybrid methods I sought to measure the varying 
affinities of Sla2p with its interacting partners upon phosphorylation (Figure 3.9 A, B 
and D). Sla2p, full length or coiled-coil domain alone (283-501 amino acids) was 
cloned in frame into pGBKT7 vector (Clontech) and the interacting partners were 
cloned in-frame into pGADT7, unless otherwise stated (see Chapter 2 Table 2.2 for 
details on constructs) Dimerization along with interactions with Sla1p were not 
significantly affected by phosphorylation status of Sla2p (data not shown). Clc1p’s 
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interaction with Sla2p’s coiled-coil domain was difficult to determine as Clc1p could 
strongly induce -galactosidase activity on its own (auto activity, data not shown).  
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p showed marked decrease in interaction with Scd5p N-
terminal (2-534 amino acids). Quantification of -galactosidase activity from the 







p showed similar levels of interaction. This 
experiment was repeated on three different clones, correctly expressing both fused 
proteins. The interaction between Sla2p and Scd5p is weak and/or transient. In the 
yeast-2hybrid experiment, the -galactosidase unit levels are very low (Figure 3.9 A) 
and co-immunoprecipitation results and GST-pulldown bands are very weak. The 
interaction between Sla2p and Scd5p is further characterized in chapter IV. 
Pan1p was another interacting partner of Sla2p whose affinity was strongly 
dependant on phosphorylation on Sla2p (Figure 3.9 C and D). Pan1p’s coiled-coil 
domain (640-1310 amino acids) has been implicated in mediating interaction with 
Sla2p’s central coiled-coil domain. Pan1p’s coiled-coil domain was cloned in-frame 
into pGADT7 vector and expressed along with Sla2p’s in pGBKT7 in SFY526 strain 
and then -galactosidase activity of at least 3 different colonies were monitored by 
spectrophotometry. In contrast to Scd5p, Pan1p’s coiled-coil domain interacted more 
strongly with the phospho-mimetic mutant Sla2
EE
p than wild-type or Sla2
AA
p. Using 
GST-pulldown, where the 283-501 amino acid fragment of Sla2p and its phospho-
mutants were expressed as an N-terminal GST fusion protein from E.coli cells, and 
were tested for their ability to bind to wild-type Pan1p protein tagged with an C-
terminal HA-tag expressed in yeast. In this assay, Sla2
AA
p was found to have very 
basal level binding with Pan1-HA while Sla2p and Sla2
EE
p showed strong binding of 
similar intensity (Figure 3.9C). This corroborates the earlier finding that Sla2p is 
phosphorylated by kinases in the yeast cytosol. In the nuclear milieu, where Gal4BD- 
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fused Sla2p is translocated, the wild-type protein is likely to be unphosphorylated as 
Ark1/Prk1 family of kinases are restricted to the cytosol. Thus the GST-pulldown as 
well as yeast 2-hybrid assays show that Pan1p preferentially binds to phosphorylated 
Sla2p.  
Ark1p was initially identified as a binding partner for Sla2p and given that it 
plays a role in phosphorylating Sla2p, I was interested in studying the effect that 
phosphorylation would have on their binding. Ark1p binds to the C-terminal portion 
of Sla2p (more details in Chapter V) so the entire middle and C-terminal region (310-
968 amino acid) of Sla2p was cloned in-frame into the pGBKT7 vector and tested for 
interaction against C-terminal Ark1p (298-638 amino acid, non-kinase domain) fused 





observed. This correlated with the fact that Ark1p dynamics is unperturbed by Sla2p’s 




3.4 Sla2p interacts with Scd5p and can be 
dephosphorylated by the protein phosphatase-1, Glc7p 
Phosphorylation is a reversible post-translational modification that alters the physical 
and functional properties of a protein. It usually is a very rapid process, hence used as 
an on/off switch in many signaling and regulatory pathways. Sla2p is phosphorylated 
by Prk1p in vivo, which modulates its function subtly. In order to maintain a pool of 
unphosphorylated protein, a dephosphorylation step must occur. Recently, Zeng et al 
demonstrated that Glc7p, along with its regulatory subunits Scd5p and End3p, are 
able to dephosphorylate several targets of Prk1p, namely Pan1p, Sla1p and Scd5p 
itself. Sla2p had been shown to be a binding partner of Scd5p in a screen (Henry et 
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al,) and I thought that it too might be target of Glc7p mediated dephosphorylation.  I 
first validated and dissected the interaction between Sla2p and Scd5p and then went 
on to study the dephosphorylation of Sla2p, both in vitro and in vivo.  
3.4.1 Sla2p and Scd5p interact with each other using their C-
terminal and N-terminal regions respectively 
The interaction between Sla2p and Scd5p had been shown by yeast-2 hybrid (Y2H) 
assay (Henry et al, 2003) but this had never been validated by other techniques such 
as co-IP or in vitro binding assay. The specific regions in the two proteins that interact 
had not been studied. The interactions between these two proteins are described in 
great detail in Chapter IV. Using co-immunoprecipitation techniques I determined 
that the interaction between full-length Sla2p-HA and full-length Scd5p-Myc 
occurred in vivo, in the natural states of the proteins (Chapter 4, figure 4.4). As 
observed in the yeast 2-hybrid experiment, the interaction was not especially strong 
and is likely to be transient in vivo. However, this confirmed that Sla2p and Scd5p did 
bind to each other in a cellular milieu.  
Further dissection of this protein-protein interaction is done in Chapter IV of 
this thesis, in the context of Sla2p’s C-terminal region. In the following sections of 
this Chapter I explore the significance of Sla2p and Scd5p binding and how it helps in 
dephosphorylation of Sla2p. 
3.4.2 Glc7p can dephosphorylate Sla2p, both in vitro as well 
as in vivo  
Previously, the role of Scd5p/Glc7p in dephosphorylation of endocytic proteins had 
been firmly established (Zeng et al, 2007 and Henry et al, 2003). I hypothesized  that 
Sla2p would be a good candidate for dephosphorylation by Glc7p, since its interaction 
with Scd5p affords proximity with Glc7p, a protein phosphatase-1. I used the assays 
described in Zeng et al, 2007 to study the dephosphorylation mediated by the 
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phosphatase on Sla2p both in vitro and in vivo. Sla2p (280-511 amino acids) fused 
with GST was incubated with Prk1p kinase immobilized on beads, in the presence of 
ATP. This kinase reaction was then centrifuged to remove the bead-bound kinase and 
the phosphorylated Sla2p (detectable by antibodies against phosphorylated threonine 
residue, denoted as anti-pThr) was incubated with Glc7p immobilized on beads and 
aliquots were taken at 20-minute intervals. The intensity of anti-pThr signal decreased 
over time, indicating that Glc7p was able to act upon phosphorylated Sla2p (Figure 
4.3A and for quantitation, Figure 4.3B). This trend was abrogated upon addition of I-
2, a specific inhibitor of type-1 phosphatase (Figure 4.3A and B).  
In order to observe this reaction in the cytoplasm, I used the strains glc7-td 
and glc7-ntd containing heat-inducible, degradable version of Glc7p and non-
degradable version of Glc7p, respectively. Sla2p was tagged, at the C-terminus, with 
Myc epitope at the genomic locus. Cells were shifted up to 37
o
C wherein the 
degradation signal in glc7-td would target the protein for degradation. The protein in 
glc7-ntd strain would not be shunted into the degradation pathway, leaving Glc7p 
protein levels intact (Zeng et al, 2007, data not shown). After shifting to higher 
temperature, aliquots of cultures were taken every 20 minutes and probed with anti-
pThr in a western blot. In glc7-td cells, an increase in Sla2p phosphorylation is 
observed with the concomitant decrease in Glc7p levels. In contrast, both levels of 
Sla2p phosphorylation as well as amount of Glc7p remains unchanged in glc7-ntd 
cells. This shows that reduced Glc7p levels result in a concomitant increase in levels 
of phosphorylated Sla2p and this places Sla2p to be a likely substrate of Glc7p.  
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In this chapter I have shown Sla2p to be regulated by carefully orchestrated 
events of phosphorylation and dephosphorylation that reflect upon its function, in 
both actin organization as well as endocytosis. This study sheds light on the subtle 
regulation that occurs at the cell cortex, which fine-tunes the process of endocytosis 
and actin polymerization associated with it. Sla2p appears to be solely modified by 
the Prk1/Ark1 family of kinase as deleting the two proteins affords minimal 
phosphorylation on threonine residues (Figure 3.1D). Previously identified targets of 
these kinases were shown to contain motifs of the form [L/I/V/M]xx[Q/N/T/S]xTG 
that specifically targeted for phosphorylation at the threonine residue (underlined) 
(Huang et al, 2003, and Zeng and Cai, 1999). Mutation of both threonines to alanine 
completely abolished phosphorylation as well (Figure 3.1B). The two phosphorylation 
sites of Sla2p lie just upstream of Sla2p’s central coiled-coil domain (Figure 3.1A)- a 
segment of the protein that is highly essential for localization, function and survival. 
The central coiled-coil domain has been implicated in mediating vital protein-protein 
interactions such as dimerization, interactions with Sla1p, clathrin etc. Deletion of this 
region was found to cause severe actin defects, endocytic defects and temperature 
sensitive phenotype (Yang et al, 1999 and Wesp et al, 1997). The mutant protein also 
lost its dotted cortical localization and was found diffused all over the cytosol. I 
hypothesized that phosphorylation near this region could play a role in modulating 
various aspects of Sla2p’s function. Intriguingly, what I found was a very subtle and 
interesting phenomenon upon creating unphosphorylatable (TA) and phospho-
mimetic (TE) mutants of Sla2p (Sla2AAp and Sla2EEp, respectively). Firstly, I had 
observed that while gross localization and function remained undisturbed, on the 
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microscopic, cortical level sla2
EE
 mutant showed some very interesting phenotypes. 
The lifespan of Sla2
EE
p was about 9 seconds longer than wild-type Sla2p (Figure 3.3). 
In this sla2
EE
 mutant strain, cortical lifetimes of other components of the endocytic 
coat such as Abp1p, Sla1p and Pan1p (Figures 3.4, 3.5 and 3.6) were also statistically 
significantly increased. However, amongst all these coat components Pan1p was most 
severely affected; sla2
EE
 caused a delay in Pan1p path dynamics of more than 10s.  
The delay in coat-protein dynamics observed in the phospho-mimetic mutant 
correlated with the slight decrease in receptor-mediated endocytosis (Figure 3.8A). 
Other forms of endocytosis, which are tracked using dyes, were more difficult to 
quantitate and showed virtually no defect in endocytosis. This could be due to a 
limitation of the techniques involved or that bulk-phase endocytosis has slightly 
different mechanisms in which phosphorylation status of Sla2p does not play a big 
role. 
In order to explain the visual data on molecular terms, I sought to find out 
whether the phosphorylation by Prk1p at positions 341 and 329 had any effect on 
Sla2p’s affinity towards its binding partners. As mentioned earlier, the 
phosphorylation sites lie just N-terminal of the first coiled-coil domain of Sla2p 
(Figure 3.1A), which has been implicating in mediating several key interactions such 





p were able to interact with Sla1p, Clc1p and itself at similar levels (co-
immunoprecipitation data not shown). These techniques were not quantitative enough 
to detect small changes in binding affinities that this post-translational modification 
seemed to bring about and therefore, I used the more sensitive quantitative yeast 2-
hybrid assays. This binding assay revealed that, while Sla2p’s affinity for most 
proteins remained unaffected upon phosphorylation, it was not able to bind Scd5p in 
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its phosphorylated state. The affinity for Sla2
EE
p for Scd5p was much less than that of 
Sla2p wild-type and conversely, Sla2
AA
p showed a much greater affinity for the same 





p (Figure 3.9 C and D). This suggests that Scd5p preferentially binds 
to a pool of Sla2p that is unphosphorylated while Pan1p binds to the predominant 
fraction of Sla2p that is in the phosphorylated state. I have also shown that via 
binding to Scd5p, Sla2p can be targeted to Glc7p, which dephosphorylates it. A pool 
of unphosphorylated Sla2p will be required to ensure efficient endocytic coat 
formation and subsequent internalization of the vesicle. Using assays described in 
Zeng et al (2007) to study dephosphorylation in vivo and in vitro, I was able to show 
that Sla2p was a target for dephosphorylation by the Scd5p/Glc7p complex.  This fits 
nicely with the proposed model that Sla2p’s function is regulated by antagonistic 
process of phosphorylation by Prk1p and dephosphorylation by Scd5p-Glc7p 
complex. 
The very intriguing phenomenon of slower actin patch dynamics as well as 
decrease in affinity for Scd5p in Sla2
EE
p cells leads me to hypothesize on the exact 
mechanism that might be behind these observations. Sla2p is a multivalent, scaffold 
protein that appears early in the endocytic schematic. Its role, presumably, is to 
integrate the endocytic machinery with the actin module. It can conceivably do this by 
recruiting the various components and nucleating the assembly of the various coat 
proteins such as Sla1p, Scd5p etc. Scd5p, at the cortex, is an important entry point for 
the phosphatase Glc7p. Dephosphorylation of Pan1p, by Glc7p, is important for its 
function in activating the Arp2/3 complex. Sla2p may function as the crucial factor to 
bring Scd5p to the cortical patch. Since Sla2
EE
p is unable to bind Scd5p efficiently, its 
recruitment could be delayed. This can cause an overall delay in the formation as well 
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as inward movement of the nascent coat, which I have been able to observe via live-
cell time-lapse fluorescent microscopy. Furthermore, Sla2p and Pan1p show very 
similar lifespan at the cortex and are known to appear and disappear almost 
simultaneously from the cortex. Sla2p is also a negative regulator of Pan1p. 
Dephosphorylation of Pan1p seems to be vital in order for it to activate Arp2/3 
complex. Scd5p and End3p appear to be candidate proteins to introduce Glc7p to 
Pan1p. However, Scd5p has very low affinity for phosphorylated Pan1p (Zeng et al, 
2007) and End3p is hypothesized to bind to Scd5p and hence bring Glc7p to its 
substrate. However, Sla2p is also an attractive candidate for this job as, like End3p, it 
too binds to Pan1p and Scd5p. Intriguingly, both Sla2p and phosphorylation of Pan1p 
by Prk1p negatively regulates the Arp2/3 activation ability of Pan1p (Toshima et al, 
2007). It is possible that both Sla2p and Pan1p are phosphorylated at the same time 
since Prk1p appears at the patch at a strictly coordinated manner. If that is indeed the 
case, phospho-Pan1p will remain inactive. Simultaneously, phosphorylated Sla2p will 
prevent Scd5p from being recruited to the patch efficiently, thereby decreasing the 
level of Pan1p dephosphorylation and creating a negative feedback loop. I have 
observed a slight increase in Pan1p phosphorylation in sla2
EE
 background (data not 
shown). I would like to further investigate this phenomenon in the future. 
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current understanding as to how these three proteins might function at the cell cortex. 
Sla2p is known to be a negative regulator of Pan1p’s NPF activity (Toshima et al, 
2007) and together with phosphorylation by Prk1p, aid in keeping Pan1p inactive at 
endocytic sites (Toshima et al, 2005). The stronger affinity of Pan1p for the 
phosphorylated Sla2p will then probably act as a negative feedback loop, ensuring 
Figure 3.11 Model explaining the effects of phosphorylation and dephosphorylation of Sla2p in 
the endocytosis cycle. Pan1p and Sla2p are early endocytic proteins that assemble at the cortex (1). At 
this point Pan1p is active and stimulates Arp2/3 dependant actin polymerization, which helps in 
curvature of the membrane (2). As the vesicle begins to mature and pinch off, proteins like Abp1p, 
Prk1p etc are recruited. Prk1p phosphorylates Pan1p and Sla2p and inhibits Pan1p’s NPF. 
Phosphorylation also increases the affinity between Pan1p and Sla2p, which further inhibits Pan1, thus 
forming a negative feed back loop (3). As the vesicle pinches off, actin polymerization initiated by 
other NPFs like Abp1p, pushes the nascent vesicle away from the membrane and the coat disassembles 
(4). Pan1p and Sla2p are still in a complex. At this point, the Scd5p/Glc7p is proposed to approach the 
binary complex and bind to Sla2p with lower affinity and cause its dephosphorylation (5). As Sla2p get 
dephosphorylated, its affinity for Scd5p increases creating a positive feedback. This in turn leads to 
increased dephosphorylation of Pan1p and its eventual reactivation. Unphosphorylated Sla2p has lower 
affinity for Pan1p, hence the two proteins separate and recycle back to the membrane where Pan1p can 
activate Arp2/3 again (6). 
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that Pan1p remains phosphorylated, Sla2p-bound and inactive. Both Pan1p and Sla2p 
are natively found in the phosphorylated form (Toshima et al, 2005, Zeng et al, 2007 
and this study) and it is not unreasonable to assume that both these proteins are 
phosphorylated in a similar time frame. Moreover, Prk1p and Ark1p appear and 
disappear from the cortex while Pan1p and Sla2p are still present (Zeng et al, 2007, 
Jin and Cai, 2008, this study). So the phosphorylation event is likely to strengthen the 
bond between Sla2p and Pan1p and no actin polymerization is seen at the stationary 
phase of the vesicle (see Figure 1.6). Scd5p and Sla2p have a weak affinity for each 
other and the interaction is further reduced by phosphorylation on Sla2p. 
According to the model I am proposing, binding of Scd5p to Sla2p brings 
about dephosphorylation that would serve to strengthen interaction between Scd5p 
and Sla2p and at the same time, weaken the bonds between Pan1p and Sla2p. 
Proximity to Scd5p to Pan1p via Sla2p could serve as a second entry point for Glc7p 
to access and dephosphorylate Pan1p. End3p was proposed to fulfill a similar function 
(Zeng et al, 2007). 
 
3.6 FUTURE WORK AND PERSPECTIVES 
Phosphorylation appears to be an important regulation in the function of Sla2p. In this 
chapter I have shown that the phosphorylation status of Sla2p affects its own cortical 
dynamics as well as that of other proteins associated with the endocytic machinery. 
The difference in the dynamics is small but significant, indicating that 
phosphorylation of Sla2p aims subtly modulate the actin and endocytic machinery at 
the cortex. Since Sla2p has only 2 phosphorylation sites, the effect is slight but it 
spills over to other proteins associated with the complex. Phosphorylation of other 
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proteins like Pan1p and Sla1p have more drastic effects since each protein contains 
>20 Prk1p consensus motifs.  
 My study opens up many more avenues of discovery in Sla2p function. It 
would be interesting to know what proportion of Sla2p is phosphorylated in the 
cellular milieu.  Unpublished data shows that only about 20% of the total pool of 
protein is phosphorylated. In vitro kinase results show that Prk1p can equally 
phosphorylate both the sites on Sla2p. However, physiologically each of these sites 
may be differently phosphorylated. It would be interesting to use techniques like 
mass-spectrometry to determine which site is preferentially phosphorylated during 
endocytosis. 
 Additionally, I would be most interested to further study the effect of 
phosphorylation on protein-protein interaction and its effect. In particular, the 
interaction between Sla2p and Pan1p is important. I would like to use in vitro actin 
polymerization studies to see if Pan1p’s polymerization activating function is affected 
by phosphorylation on Sla2p. This would help  prove the proposed model that 
phosphorylation of Sla2p can act as dominant negative loop in the inhibition of 
Pan1p. 
 With respect to dephosphorylation of Sla2p, several key points remain 
unaddressed. It would be interested in measuring the phosphorylation levels in 
various scd5 and glc7 mutants that have been shown to have lower dephosphorylation 
activity. For example, scd5-1 mutant shows defective binding to Glc7p and this 
causes increased phosphorylation of Pan1p and Sla1p (Huang et al, 2003) This data 
would further strengthen the argument that Sla2p phosphorylation is tightly controlled 
in the cell. The cortical dynamics of Scd5p was not shown as the protein has very 
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weak GFP signal. In the future, using better technique I hope to show Scd5p’s cortical 
























SECOND COILED-COIL DOMAIN OF Sla2p 
PLAYS A VITAL ROLE IN ITS FUNCTION 
4. SECOND COILED-COIL DOMAIN OF Sla2p PLAYS A 








CHAPTER IV SECOND COILED-COIL DOMAIN OF Sla2p 
101 
4.1 BACKGROUND 
Sla2p’s secondary structure prediction indicates that it contains three putative coiled-
coil domains (Figure 4.1). The central coiled-coil domain has been the subject of 
much scrutiny as it is critical for the function of Sla2p in the cell. This coiled-coil 
domain is longer than the other two domains (~200 amino acids) and its deletion is 
deleterious to the cell. The primary function of the central domain is mediating 
various dimerization, as well as interactions with Sla1p and clathrin. The other two 





Previous studies had shown Sla2p’s N-terminal portion (including the central 
coiled-coil domain) was found to be most vital as deletion resulted in mis-localization 
of the protein, impaired growth at elevated temperature, block in endocytosis as well 
as aberrant actin organization (Wesp et al, 1997, Yang et al, 1999). In these studies, 
Figure 4.1 Coiled-coil domains of Sla2p  
Three major regions of coiled-coil domains are predicted (COILS prediction algorithm) shown as 
peaks.-the central coiled-coil (283-510 a.a) ad two C-terminal coils (700-730 and 938-968 a.a). 
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Sla2p’s C-terminus was largely considered extraneous for Sla2p’s function in actin 
regulation, endocytosis and cell survival. However, over-expression of the talin-like 
region or the THATCH domain (720-968 amino acids) caused drastic actin 
cytoskeleton disorganization. I was interested in finding out the function of Sla2p C-
terminal as it had been hitherto, unknown. Firstly, I began by studying the two 
proteins that were known to bind Sla2p’s C-terminal: Ark1p and Scd5p. This 
interaction was carefully dissected and the exact domains involved in binding were 
ascribed. The course of this study revealed that the second coiled-coil domain 
extending from amino acids 700-730 was of crucial importance. In this chapter a new 
mutant of the SLA2 gene- the sla2CC mutant and its phenotypes are described in 
great detail.  
 
4.2 Sla2p C-terminal coiled-coil domain is important for its 
function 
4.2.1 Deletion of second coiled-coil domain (amino acid 700-
730) causes temperature sensitivity 
Secondary structure prediction tools show that Sla2p contains a stretch of 
residues from amino acid 700 to 730, which folds to form a coiled-coil domain 
(Figure 4.1). I deleted this region using PCR (described in Chapter 2) and created a 
Sla2p variant lacking only 30 amino acids (Sla2pCC). This mutant was expressed as 
a C-terminal HA tagged under the SLA2P gene’s native promoter and when detected 
by western blot on a 8% SDS-PAGE gel, was found to have mobility very slightly 
higher than that of the full-length protein (Figure 4.3C). When Sla2pCC was 
transformed into sla2 cells it was unable to restore growth at 37oC (Figure 4.2A). 
Alongside this mutant, I made several other systematic deletions of the Sla2p C-
terminal (Figure 4.2A) in order to study the function of the other domains in the C-
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terminus. Sla2p(1700) had the entire region after residue 700 deleted, while 
Sla2p(1730), Sla2p(1768) and Sla2p(1930) contained deletions from residues 
730, 768 and 930 onwards respectively. Sla2p(1700) and Sla2p(1730) had almost 
the whole of the THATCH domain (talin/HIP1/R/Sla2p-actin tethering-C-terminal 
homology) deleted while Sla2p(1768) retained a small portion. Sla2p(1930) 
retained nearly the entire THATCH domain but lacked the last 30 amino acids that is 
predicted to fold into the third coiled-coil domain (Figure 4.1) of unknown function. 
All the variations of Sla2p C-terminal truncations expressed under the control of the 
SLA2 native promoter were stable and detected in equal amounts in the cell, and had 
mobilities close to their predicted sizes (Figure 4.3C). All the fragments were 
transformed into the sla2 strain and were tested for their ability to complement the 
growth defects of the null mutant at 37
o
C. Drop test was performed and each plate 
was observed after 3 days. Interestingly, all the strains, except Sla2pCC, were able 
to rescue growth at high temperatures indicating that the C-terminal might play an 
essential regulatory role.  
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4.2.2 Localization and dynamics of C-terminal truncation 
mutants are different from wild-type Sla2p  
Each of the mutants was subcloned, in frame, into a vector containing a C terminal 
GFP tag. The constructs were transformed into sla2 cells and their expression 
checked by western blot (data not shown). All constructs were expressed as stable 
GFP-tagged proteins. The cells were then visualized after refreshing at 25
o
C for 1 
hour and then temperature shift at 37
o
C for 1 hour. The cells were not fixed but 
directly mounted on a slide from the culture. All the mutants displayed cortical, 
punctate localization. However Sla2CCp signal would form large clumps, about one 
in every cell at least. There appeared to be a few normal looking Sla2CCp-GFP 
signal which were motile and showed normal dynamics at the cortex. The large 
abnormal clumps were largely non-motile (Figure 4.2B).  Sla2p(1-700) showed 
abnormal-looking clumps while the normal patches appeared much dimmer. The 
other two mutant Sla2p(1-730) and Sla2p(1-930) appeared by-and-large similar to 
wild-type distribution. 
4.2.3 Actin organization and endocytosis is aberrant in some 
of the C-terminal deletion mutants 
Next, I wished to study the actin morphology of the strains carrying the various C-
terminal mutants. Most sla2 mutants have aberrant actin morphology such as patches 
depolarized to mother cells as well as aberrant actin “comet tails” and clumps. The 
various strains expressing the C-terminal mutants were cultured at 25
o
C and were 
either maintained at that temperature or shifted up to 37
o
C for 2 hours and then fixed 
and stained with rhodamine-phalloidin as described in Chapter 2. At 25
o
C, all 
mutants, except the ones carrying sla2CC mutation, showed normal polarized actin 
patch distribution. sla2CC cells showed clumps of actin in almost 80% of the cells 
and in many small budded cells, the patches were not correctly polarized to the bud 
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(figure 4.3D panel 5). However at 37
o
C, several of the other C-terminal mutants also 
showed abnormality in their actin organization. Aberrations included a distinct 
depolarization of the actin patches to the mother cell, and some showed increased 
number of patches at the cortex (Figure 4.3D panel 5). The sla2CC strain, in 
addition to depolarized patches, appeared to have short, thick cable-like actin 
structures at the cell periphery. These cells also had multiple buds in more than 70% 
of the cases. While sla2(1-700) shows perfectly normal actin cytoskeleton at 25
o
C 
,actin clumps at 37
o
C begin to appear at 37
o
C (figure 4.3D panel 2).  sla2(1-730) 
displayed higher number of patches in the mother cell at 37
o
C but no actin clumps 
while sla2(1-930) behaved almost exactly like wild-type cells. Thus these results 
prove that the C-terminal portion of Sla2p is important in maintaining proper actin 
organization at higher temperature. The second coiled-coil domain is absolutely 
essential for the function of the protein and its removal caused profound actin defects, 
reminiscent of the sla2 mutant.  
Since Sla2p is an endocytic coat protein and functions in the endocytic 
pathway, I decided to follow the progress of various endocytic cargos in these 
mutants. Cells were shifted up to 37
o
C for 1 hour prior to addition of the dye and 
visualized 1hour post-addition. Bulk phase endocytosis of Lucifer yellow dye was 
most severely inhibited in sla2CC mutants (only 10% of cells showed LY in the 
vacuole, Figure 4.3A last panel) followed by sla2(1700) (~25% of the cells showed 
vacuolar staining). The other three mutants strains showed levels of intake that were 
very similar to that of wild-type Sla2p-expressing cells (Figure 4.3A). 
Receptor mediated endocytosis is an important pathway by which cells take up 
extracellular matter and recycle components of the plasma membrane. I wished to 
study the significance of Sla2p’s C-terminal in this process by tracking the 
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internalization of a membrane receptor Fur4p. Fur4p is a uracil permease that binds to 
its cargo (uracil) and gets internalized to the vacuole in an energy dependant process. 
The assay measures the percentage of permease remaining on the cell surface, over 
time, after addition of cycloheximide to block protein synthesis. Closely mirroring LY 
uptake data, sla2CC showed a significant retardation in the internalization process 
(only 30% uptake after 80 mins, while WT cells displayed >70% uptake in the same 
time frame, figure 4.3B). Again, deletion of the entire C-terminal region, amino acids 
700 onwards, had a small but significant negative effect on Fur4p uptake. The other 
truncations showed almost no defect in internalization compared to wild-type Sla2p.  
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Figure 4.3 Effect of Sla2p C-terminal truncations on endocytosis and actin 
cytoskeleton 
A: Fluid-phase endocytosis at 37
o
C in Sla2p C-terminal truncation mutants. sla2CC shows 
defect in internalization of soluble fluorescent dye Lucifer yellow (LY, right most panel). Cells 
were grown overnight at 25
o
C, refreshed to OD600 of ~0.5, shifted up to 37
o
C for 1 hour and 
the dye was mixed with the cells and observed after 1 hour. LY was visualized using the GFP 
filter. 
B: Receptor-mediated endocytosis at 37
o
C in Sla2p truncation mutants. Cells were grown 
and shifted similar to what is described above. Levels of surface Fur4p were tracked for every 
strain in intervals of 20 minutes. sla2CC shows only 30% clearance of surface receptors 
after 80 minutes. sla2(1-700) too shows a milder defect in endocytosis (40% clearance after 
80 minutes). 
C: Expression levels of various truncation mutants at 37
o
C. Cells were shifted to non-
permissive temperature for 1 hour and lysed and Sla2p-Myc was precipitated using anti-Myc 
immobilized on beads. The immunoprecipates where then separated by SDS-PAGE and 
subjected to western blot using anti-Myc antibodies. All proteins were expressed as clear-cut 
bands of expected size, relative to full length Sla2p-Myc. 
D: Rhodamine-phalloidin staining to visualize sub-cortical actin structures in Sla2p truncation 
mutants. Cells were fixed and stained with the actin-binding dye after refreshing and shift up 
to respective temperature. sla2(1-700) (panel 2) showed abnormal actin clumps at 37
o
C but 
not at lower temperature, while sla2CC cells had clumps at both permissive as well as non-
permissive temperatures (panel 5). The other mutants showed phenotypes similar to wild-
type Sla2p at both temperatures (panel 1, 3 and 4). 
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4.3 Sla2p C-terminal coiled-coil mediates interaction with 
Ark1p and Scd5p and affects their localization 
The C-terminal region of Sla2p was shown above to be very important for its function 
in endocytosis and actin organization; hence I tried to understand the molecular 
interactions mediated by this domain. Sla2p was shown to interact with two proteins 
via its C-terminal- Ark1p and Scd5p (Henry et al, 2002 and Cope et al, 1999). The C-
terminal of Sla2p (amino acids 503-968) was used as bait in a screen for interacting 
partners and Ark1p was one of the candidates that were found (Cope et al, 1999). 
However, this interaction was never fully characterized by other methods and the 
exact region of Sla2p and Ark1p was never completely elucidated. Similarly, a two-
hybrid screen using Scd5p N-terminal as bait identified a large C-terminal fragment 
of Sla2p (from amino acid 292-968) (Henry et al, 2002). Identifying the exact 
sequences in each protein that are responsible for the interactions would help 
understand the function of each protein. 
4.3.1 Sla2p and Ark1p interaction domain analysis 
I first examined the interaction between Ark1p and Sla2p. The only other 
evidence of this interaction is found in Cope et al, 1999, where Sla2p C-terminal was 
used as bait and isolated Ark1p C-terminal (non-kinase domain) as one of its partners. 
The authors of that paper did not go on to confirm this finding in vivo or by any other 
methods other than yeast 2-hybrid. The fragment spanning 503-968 amino acids of 
the Sla2p protein that encompasses the THATCH domain as well as the second 
coiled-coil domain (amino acids 700-730) discussed earlier. This rather large 
fragment of Sla2p pulled up two overlapping C-terminal region of Ark1p (380-552 
amino acids). This is the non-kinase portion of Ark1p, which is very divergent from 
the similar region of its homologue, Prk1p.  
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I made use of a series of truncations starting from the C-terminal (Figure 
4.2A), deleting one predicted domain at a time. The N-terminal and central coiled-coil 
regions were eliminated completely as I was interested in solely the C-terminal 
portion of Sla2p. Sla2p(501-938) consisted of amino-acids 501 onwards with the 
exception of the last 30 residues, purported to fold into a coiled-coil domain. 
Sla2p(501-768) consisted of a portion of the THATCH domain while Sla2p(501-730) 
did away with the entire THATCH domain but contained the second coiled-coil 
domain. Sla2p(501-700) was a short fragment which did not have the second coiled-
coil domain nor the THATCH region. These fragments of Sla2p were fused to GAL4 
activation domain (pGADT7 vector from Clontech) and tested for their ability to bind 
with Ark1p C-terminal fused to GAL4 DNA binding domain. The longer fragments 
Sla2p(501-968) and Sla2p(501-938) were able to bind robustly with Ark1p-C and 
while Sla2p(501-730) and Sla2p(501-768) were still able to bind, the interaction was 
slightly weaker. Sla2p(501-700) showed no interaction with Ark1-C-terminal 
whatsoever (Figure 4.4B). This proved that the coiled-coil domain is absolutely 
essential for the interaction between Sla2p and Ark1p, while some residues of the 
THATCH domain might aid in stabilizing the bond. 
In order to further confirm the results of the yeast 2-hybrid assay, I performed 
GST pulldown using the same fragments described above. The C-terminal fragment 
were fused to N-terminal GST fusion proteins and expressed and purified from E.coli. 
The recombinant proteins were used to pull down C-terminally HA labeled Ark1p 
from the cytoplasmic milieu of yeast cells. Ark1p was efficiently pulled-down by the 
almost complete Sla2p C-terminal (580-930 amino acids) however 
Sla2p(580700) was unable to bind with Ark1p above background levels (Figure 
4.4C, lanes 4 and 2 respectively). Interestingly, Sla2p(580-730) was able to bring 
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down Ark1p, albeit, a lot less efficiently compared to the complete Sla2p C-terminal. 
This result corroborated the yeast two-hybrid results that show amino acids 700-730, 
constituting the second coiled-coil domain in Sla2p, is vital for the interaction 
between Sla2p and Ark1p.  Interestingly, the central coiled-coil domain is not 
important for binding to Ark1-HA (figure 4.4C lane 1). 
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4.3.2 Sla2p and Scd5p interaction domain analysis 
Similar to Ark1p, the interaction between Sla2p and Scd5p had been reported in yeast 
2-hybrid screens but the finer aspects of this connection were not found in literature 
(Henry et al, 2002). In this paper, the authors fused first 534 amino acids of Scd5p to 
GAL4 DNA binding domain and used as bait and was tested against two fragments of 
Sla2p: 292-501 amino acids and 292-968 amino acids. Only the longer fragment, 
containing the entire C-terminal region as well as the second coiled-coil domain was 
found to have positive interaction with Scd5p.  
Firstly, I wanted to show that Sla2p and Scd5p form a complex in vivo. I 
tagged the proteins with C-terminal Myc or HA respectively, at their gene locus. The 
cells were lysed and immunoprecipitation was performed using polyclonal HA or 
Myc antibodies immobilized on sepharose beads. Sla2p-Myc bound to anti-Myc 
beads was able to pull down Scd5p-HA (Figure 4.5B lane 2). This leads us to 
conclude that Sla2p and Scd5p are present in a complex within the cell, under 
physiological conditions.  
Next, I was interested in zoning in on the exact domain of Sla2p involved in 
binding with Scd5p. Using the same constructs described earlier (Sla2p-C-terminal 
truncations cloned into pGADT7) I performed the quantitative yeast-2 hybrid analysis 
using Scd5p N-terminal as bait. Figure 4.4A shows that Scd5p-N shows robust 
interaction with full length Sla2p but Sla2p(310-930) showed the strongest 
interaction, hinting that the N-terminal portion of Sla2p might somehow 
intrasterically inhibit the binding. The central coiled-coil domain (amino acids 310-
580) was not able to interact with Scd5p at all. Interestingly, Sla2p(310-730) showed  
significant interaction with Scd5p but Sla2p(310-700) showed basal level -
galactosidase activity, implying a lack of affinity. Again the second coiled-coil 
domain found between 700-730 is absolutely necessary for binding to Scd5p.
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4.3.3 Sla2p C-terminal affects localization and dynamics of 
Ark1p 
Having established that the C-terminal coiled-coil domain is crucial in Sla2p’s 
interaction with Ark1p, I was curious to find out whether this interaction affected the 
localization of Ark1p in anyway. Ark1p was previously showed to have normal 
looking punctate localization in sla2 cells (Cope et al, 1999). The visualization in 
the study appeared to show high background as the authors had to over-express 
Ark1p-GFP.  I too was able to observe the punctae of Ark1p-GFP in sla2 strain, and 
many of the abnormal actin clumps contained the kinase (data not shown). The same 
strains mentioned above, containing the various C-terminal mutants, were used to 
integrate a GFP tag at the Ark1p locus. The experiment revealed some very 
interesting data: in sla2CC cells, Ark1p appeared as distinct dots, occasionally co-
labeling with the abnormal actin structures that can be observed in this strain. The 
lifespan of Ark1p was unaffected and was very similar to that of Sla2p wild type 
strain (WT: 13.5+3.3s, CC: 14.1+1.8s, Figure 4.4D.). In contrast, Ark1p in sla2(1-
700) and sla2(1730) displayed much diffused cortical staining. Ark1p appeared to be 
mislocalized in the cytoplasm and showed much fewer patches (Figure 4.5A panels 2 
and 3). The lifespan of Ark1p too were elongated (700: 21.8+4.4s, 730: 20.1+2.7s, 
Figure 4.4D). In sla2(1-938) Ark1p had normal localizations. These results point to 
the fact that although the second coiled-coil domain of Sla2p is important for 
interaction with Ark1p, the rest of the C-terminal domain, including the THATCH 
domain, may be important in guiding the localization of Ark1 protein. 
4.3.4 Localization and dynamics of Scd5p in sla2 mutants 
I attempted to see if the localization of Scd5p-GFP was affected in any of the Sla2p 
truncation mutant backgrounds. The GFP signal obtained from tagging Scd5p was 
incredibly weak and inconsistent with strains. When I did manage to get a signal the 
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localization of the protein looked very diffused in all the C-terminal truncation (data 
not shown). It proved to be impossible to do a patch lifespan calculation due to the 
high level of background noise observed. 
 
4.4 DISCUSSION  
4.4.1 Relevance of the Sla2p C-terminal region 
Although the function and importance of Sla2p in endocytosis and actin regulation 
has been much studied, the mechanism of its functions has never been fully 
understood. The N-terminal and central coiled-coil domain of Sla2p were found to be 
vital for the function of the protein while no function of the F-actin binding THATCH 
domain had been reported. In studies where fragments of Sla2p were expressed in 
sla2 cells to complement the temperature sensitivity, only the coiled-coil domain 
and N-terminal fragments offered growth advantage to the null mutant. Combining a 
sla2-talin mutation with deletions of yAP1801, yap1802 along with either ent1 or 
ent2 showed that the THATCH domain was important for receptor-mediated 
endocytosis only at 37
o
C(Baggett et al, 2003). This paper revealed that the mutant 
isolated, sla2-432, had a nonsense mutation after the 792
nd
 amino acid residue, which 
resulted in ablation of the entire THATCH domain barring 24 amino acids. This 
mutant was temperature sensitive for growth, in combination with deletions of either 
ent1  or ent2 and was unable to internalize Ste3p, a plasma membrane receptor, in 
combination or by itself. The sla2-432 mutant also displayed abnormal actin 
aggregates associated with the cortex, at both permissive and non-permissive 
temperatures, but the penetrance and severity of this phenotype was much less 
compared to the sla2 strain. The function of the THATCH portion of Sla2p appears 
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to be restricted to receptor mediated endocytosis and actin organization, while 
inessential for growth at higher temperature and bulk endocytosis. 
 The THATCH domain contains I/LWEQ motif, which has been has been well 
defined in terms of structure as well as function (McCann and Craig, 1997 and 1999). 
This motif is known to bind filamentous actin and is well conserved from yeast to 
mammals. The I/LWEQ functions as a dimer and is thought to stabilize the actin 
filaments that it binds to. Mammalian THATCH domain containing proteins Talin1, 
Talin2 and HIP1R contain a short sequence just upstream of the I/LWEQ containing 
domain, known as the USH (for upstream helix). As the name suggests, this stretch of 
~35-40 amino acids folds into an -helix and inhibits the THATCH domain’s ability 
to interact with actin (Senetar et al, 2004). Analysis in mammalian proteins Talin1/2 
and HIP1R have directly shown that this upstream helical domain greatly diminishes 
the I/LWEQ motif’s affinity for filamentous actin. The evidence for such kind of 
regulation in Sla2p can be inferred from yeast-2hybrid data that shows that a 
THATCH region (amino acids 768-968) is able to interact with actin but a longer 
fragment (amino acids 751-968) is not (Yang et al, 1999).  
 In this study I have clearly established that the C-terminal region of 
Sla2p is important for its function. I started out by making several deletions in the C-
terminal of Sla2p and expressed them in the sla2 cells. The mutation sla2CC 
mutant showed severe temperature sensitivity and defects, and this mutant is 
discussed in great length in the section following. The sla2(1730) strain displayed 
slight slow growth phenotype at 37
o
C but the rest of the mutants, were capable of 
growing just like wild-type cells. In terms of endocytosis, deletion of the C-terminal 
region did not cause discernible decrease in uptake of dyes like FM4-64 (data not 
shown) and Lucifer Yellow (Figure 4.2), which track bulk-phase endocytosis. 
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However, sla2(1-700) mutation was slightly deficient in the uptake of Fur4p, a 
membrane spanning protein as well as the water-soluble dye Lucifer yellow (Figure 
4.3A and B). sla2(1-700)  showed normal cytoskeleton at 25
o
C but after shift to 
higher temperature, had actin clumps in some of the cells. However, the clumps were 
smaller than that seen in sla2 and sla2CC cells, and some normal actin patches 
were still observed. In contrast, sla2(1-730), which contains just 30 amino acids more, 
displayed no defects in endocytosis and actin distribution. The strains expressing 
longer fragments of the C-terminal i.e. sla2(1-768) and sla2(1-938) were normal in all 
these respects. However, sla2CC was completely blocked in all types of endocytosis 
studied (Figure 4.3A and B) and receptor-mediated endocytosis was observed to be 
slower even at the permissive temperature of 25
o
C (data not shown). This study 
reports that the C-terminal region does play an important role in the function of Sla2p.  
4.4.2 Phenotype of sla2CC mutant 
This study also describes a novel and interesting mutant of Sla2p. The removal of just 
30 amino acids, constituting the second coiled-coil domain (sla2CC), had 
profoundly deleterious effects on the cell. The mutant was temperature sensitive for 
growth at high temperature and displayed drastic actin abnormalities even at 
permissive temperature. Furthermore, this mutant was also severely deficient in 
endocytosis. The protein was expressed at levels similar to full length Sla2p and its 
localization and time-span at the cortex remained similar to the wild type protein. 
Thus the second coiled-coil domain has very important and specific functions in actin 
organization and endocytosis. Interestingly, longer truncations of the C-terminal 
portion of Sla2p did not have such a drastic phenotype as the sla2CC mutant.  
 Actin organization of sla2CC cells was drastically altered. Large, non-motile 
clumps of polymerized actin were seen in these cells, which were highly reminiscent 
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of sla2 cells. The Sla2pCC protein itself still maintained cortical localization 
(Figure 4.2B) but were restricted to the large clumps as seen with actin. Some normal 
patches were still present, however, and these patches displayed normal kinetics (data 
not shown). Given the discovery that deletion of the entire C-terminal of Sla2p gave a 
very mild phenotype, this mutant proved all the more intriguing. The explanation of 
abrogated Ark1p/Scd5p binding would not sufficiently address the severity of the 
phenotype since another mutant -the sla2(1700) also was unable to complex with 
these proteins but displayed no temperature sensitivity nor gross endocytic defects.  
 The second coiled coil domain lies just ahead of the talin-homology or 
THATCH domain of Sla2p. This domain contains an I/LWEQ actin-binding module 
that has been very well conserved in most eukaryotes. Mammalian proteins that 
contain this domain include Talin1, Talin2 and HIP1R, a homologue of Sla2p. 
I/LWEQ domain functions as a dimer and is thought to stabilize actin filaments 
(Senetar et al 2004). The aforementioned study uncovered a very crucial bit of 
information about the regulation of this domain. Senetar and colleagues discovered a 
stretch of 40-45 amino acids present just upstream of the beginning of almost every 
THATCH domain containing protein. This peptide sequence was shown to fold into 
an -helical structure and hence named USH (for upstream helix). This sequence 
showed far lesser homology within the THATCH containing protein family, 
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domain, THATCH domains of Talin1, Talin2 and HIP1R displayed a much lesser 
affinity towards filamentous actin. Removal of the domain resulted in a tight 
association between actin and I/LWEQ. Although the authors did not analyze the C-
terminal THATCH domain of Sla2p, they cite examples in the literature where such a 
modulation is seen for Sla2p’s C-terminal. In a study by Yang et al in 1999, a Sla2p 
fragment ranging from amino acids 768-968 was found to interact with actin in a 
yeast-2hybrid assay. However, another fragment encompassing the region from 751-
930 amino acids, which contains the entire I/LWEQ region and some amino acids 
upstream of it, was unable to bind to actin.  
Figure 4.6 Intrasteric inhibition of the I/LWEQ motif by the upstream -helix 
The upstream helix (USH) shown as a yellow bar physically blocks the association of the motif with 
filamentous actin (Reproduced with permission from Senetar et al, 2004 Biochemistry Volume 43, Issue 
49) 







In Sla2p, the USH region is thought to extend from residue 720 to 770. The highly 
conserved glutamic acid residue falls at position 746. The hypothesis is that the 
severity of the Sla2CCp protein can be explained on the basis of this finding. The 
deletion ablates 10 amino acids of the helix, which presumably destroys its secondary 
structure. The THATCH domain of the Sla2CCp protein remains uncovered and its 
binding to F-actin is unchecked. The I/LWEQ motif is known to stabilize actin 
Figure 4.7 I/LWEQ super family 
A: I/LWEQ containing proteins and their module organization 
B: Conserved features of the I/LWEQ motif. The five conserved -helices (h1-h5) are the structures that 
interface with filamentous actin. A small stretch of amino acids found just in front of h1 comprises the 
upstream -helix (USH) 
C: USH sequence alignment. Structurally conserved sequences are shaded in grey. Black shading shows the 
only conserved residue – glutamine- in this domain. 
(Reproduced with permission from Senetar et al, 2004 Biochemistry, Volume 43, Issue 49) 
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filaments against depolymerization (Senetar et al, 2004), which would explain the 
appearance of abnormally large actin clumps observed in sla2CC cells. The actin 
filaments formed at the point of endocytosis are not able to depolymerize but 
accumulate instead- causing a block in endocytosis. Corroborating this hypothesis is 
the fact that over-expressing just the THATCH domain of Sla2p was deleterious to 
survival and caused immense actin defects (Yang et al, 1999). Thus unfettered 
association of Sla2p with filamentous actin causes immense cytoskeletal defects and 
eventually leads to cell death at high temperatures. It can be inferred that the 
association between actin and Sla2p is carefully regulated and in the absence of this 
regulation severe cytoskeletal defects ensue. 
4.4.3 Sla2p’s second coiled-coil domain is essential for 
interaction with Ark1p and Scd5p 
Interaction of Sla2p between Ark1p and Scd5p had never been completely 
characterized in literature, although it had been long known that these proteins 
interacted with Sla2p. While I was characterizing these interactions, a striking 
observation was made. Both these proteins interacted predominantly with the C-
terminal portion of Sla2p as opposed to the central coiled-coil domain. Systematic 
truncation of the C-terminal, which removed one domain at a time, revealed that a 30 
amino acid stretch constituting the second coiled-coil domain of Sla2p was necessary 
for a robust interaction (Figure 4.3 B and C, figure 4.5 A and C). These observations 
placed this hitherto uncharacterized domain in the crux of endocytic regulation. 
Sla2p’s C-terminal can be thought to function as a switch, which is able to bring 
about phosphorylation of the coat complex via Ark1p or its antagonistic process via 
the entry of Scd5p/Glc7p complex. The fact that both these proteins bind at a similar 
region, hints that competitive binding may play a role in this switching mechanism. It 
ought to be noted that Sla2p’s exhibits far greater affinity for Ark1p than for Scd5p. 
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Also interaction with Ark1p is less dependent on the phosphorylation state of Sla2p 
while Scd5p preferentially binds to dephosphorylated protein. Thus removal of Ark1p 
is likely to be brought about by some other displacement mechanism, which is not yet 
known. Alternatively, the binding of the two proteins could be controlled in a spatio-
temporal manner (refer to model proposed in chapter III, figure 3.11). 
 
4.5 FUTURE WORK AND PERSPECTIVES 
These findings hint at new perspectives of Sla2p function yet they raise further 
questions. For instance, the exact function and mechanism of Sla2p’s THATCH 
domain binding to F-actin is not known. Since the USH region intrasterically inhibits 
the THATCH domain, it will be crucial to know what proteins and/or conformation 
changes are required to relieve the inhibition. It will also be interesting to know how 
exactly, Sla2p filament stabilizing activity plays a role at the point of endocytosis. 
Sla2p has been considered a negative regulator of Pan1p, a very potent NPF of the 
Arp2/3 complex. sla2 cells have over-polymerized actin due to the fact that Pan1p’s 
activity is unrestricted in the null mutant. However, Sla2CCp still is able to bind to 
Pan1p (early data). In order to prove my hypothesis that Sla2p’s THATCH domain 
caused the actin clumping in sla2CC cells, it would be useful to rule out the 
possibility that this mutant is no longer able to bind and deactivate Pan1p. I hope to 
address these questions in order to understand the phenomenon a little better.  
During the time of writing this thesis, I had prepared a few experiments to 
understand better the function of the THATCH domain and to prove my hypothesis 
that it is important to regulate tightly the binding between F-actin and Sla2p. I had 
created two fragments of Sla2p: one encompassing amino acids 770 to 968 and the 
other from 700 to 968. The former is the THATCH domain alone, with the USH and 
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other N-terminal regions missing. The second one contains the coiled-coil domain, 
USH along with the entire C-terminal region. These fragments were cloned this into a 
vector and put under the control of the galactose inducible GAL1 promoter for 
overexpression. Both these were transformed into wild-type cells and I tested for their 
ability to grow in galactose containing plates. Preliminary data showed that the 
expression of just the THATCH domain is toxic to the cells as previously reported. 
However, the longer fragment could grow in the presence of galactose, albeit the cells 
were sicker than wild-type cells without the plasmid. This partially proves my 
hypothesis that THATCH domain requires some regions N-terminal of it, to regulate 
actin binding. This could be achieved intrasterically or by the recruitment of other 
factors. The other phenotypes of these C-terminal Sla2p overexpressing strains are 
still in the process of being studied at the time of writing this thesis. 
Additionally, it might be interesting to find out whether proteins that bind to 
the second coiled-coil domain, for e.g. Ark1p and Scd5p, are able to regulate the 
THATCH domains binding to F-actin. This would highlight the importance of the 
second coiled-coil domain and its regulatory role. 
In order to investigate the mechanism behind sla2CC’s phenotype, I 
performed an over-expression, suppression screen to find out what protein could 
alleviate the defects of this mutant. The screen yielded very interesting results that are 
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5.1 BACKGROUND 
In the previous chapter, I described a unique allele of SLA2 gene- the sla2CC 
mutant- that was temperature sensitive for growth and displayed significant actin and 
endocytic defects. The sla2CC mutant was missing a stretch of 30 amino acids, 
which constituted a putative coiled-coil domain in the C-terminal region of Sla2p, just 
in front of the THATCH domain. I had established the importance of this domain in 
the context of interactions between Sla2p and Ark1p and Scd5p. The deletion of these 
30 amino acids produced a phenotype that was highly reminiscent of the sla2 
mutant, although the mutant protein was expressed at wild-type levels and localized 
correctly to cortical patches. Its ability to bind to actin remained intact and this region 
was known to be unnecessary for interactions with Sla1p, Clc1p, Pan1p and itself 
(Gourlay et al, 2003, Henry et al, 2002, Toshima et al, 2007, Yang et al, 1998). The 
absence of binding to Ark1p and Scd5p could not fully explain the phenotypes 
observed in sla2CC cells. I then decided to perform a high-copy suppressor screen 
to identify proteins that alleviate this phenotype, so I might better understand the 
mechanism via which the second coiled-coil domain exerts its effect in the cell.  
 
5.2 High copy suppressor screen of sla2CC mutant 
5.2.1 Identification and verification of suppressors 
The sla2CC strain was transformed with a multi-copy library fused in pRS426 
vector, which contains ura3 as the nutritional marker and ability to propagate in both 
yeast as well as E.coli cells. Cells were transformed with the library and colonies 
were plated out on URA- plates for 8 days at 25
o
C. Colonies that grew on the plates 
presumably contained a copy of plasmid from the library. Approximately 31,000 
colonies were grew on the plates, which were then replicated on URA- plates and 




C for 5 days. Medium to large colonies that were found to grow at 
higher temperature were then patched out and plasmid DNA extracted from them. 
About 116 clones were selected using these criteria. Plasmid DNA obtained from the 
positive clones was transformed into DH5 cells in order to amplify the DNA. The 
plasmids obtained were then separately transformed into fresh sla2CC strain and 
then re-checked for growth at higher temperature. Out of the 116 clones, 35 turned 
out to be false positives, as re-transformation into the test strain did not yield growth 
at higher temperature. The rest of the 82 clones were sequenced to study which genes 
were responsible for the suppression. DNA sequencing results revealed that 19 of the 
clones were of non-coding or mitochondrial nature. 21 of them gave fragments of 
Sla2p, which proved that the library more than compensated for the entire genome. It 
also proved that sla2CC mutant was not of a dominant negative nature. The Sla2p 
fragments were not further studied in detail in this thesis. The screen yielded 14 
unique coding regions that came up once or more, again showing that the screen was 
saturated. Out of the 14, 4 proved to be metabolic genes that were not investigated 
further. The 10 unique and interesting genes are described in Table 5.1.  







DESCRIPTION AND CELLULAR FUNCTION 
ABP1 YCR088C Actin binding protein (see Chapter 1) 
ARP5 YNL059C •Nuclear actin-related protein involved in chromatin 
remodeling, component of chromatin-remodeling enzyme 
complexes (INO80 complex: actin containing complex with 
helicase activity) 
•Also found in a complex containing actin, Chc1, Clc1, 
Vps1, Vps13 
GYP5 YPL249C •GTPase-activating protein (GAP) for yeast Rab family 
members, involved in ER to Golgi trafficking; exhibits 
GAP activity toward Ypt1p that is stimulated by Gyl1p, 
also acts on Sec4p; interacts with Gyl1p, Rvs161p and 
Rvs167p  
•Vesicle localization 
BFR2 YDR299W •Essential protein possibly involved in secretion; multicopy 
suppressor of sensitivity to Brefeldin A 
LHS1 YKL073W •Molecular chaperone of the endoplasmic reticulum lumen, 
involved in polypeptide translocation and folding; member 
of the Hsp70 family; localizes to the lumen of the ER; 
regulated by the unfolded protein response pathway 
•Interacts with: Sec 22, 27, 62, 63,66 
FIG2 YCR089W •Cell wall adhesin, expressed specifically during mating; 
may be involved in maintenance of cell wall integrity 
during mating 
MEC1 YBR136W •Genome integrity checkpoint protein and PI kinase 
superfamily member; signal transducer required for cell 
cycle arrest and transcriptional responses prompted by 
damaged or unreplicated DNA; monitors and participates in 
meiotic recombination 
LCD1 YDR499W •Essential protein required for the DNA integrity 
checkpoint pathways; interacts physically with Mec1p 
ZIP1 YDR285W •Transverse filament protein of the synaptonemal complex; 
required for normal levels of meiotic recombination and 
pairing between homologous chromosome during meiosis; 











The screen yielded 9 unique genes and each of their known functions is listed above. 
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5.3 ABP1 identified as a high copy suppressor of the 
sla2CC mutant 
I decided to divert our focus on one of the genes, which came up in three distinct 
clones during the screen. ABP1 was found in conjunction with its neighbouring gene, 
FIG2 in two of the clones and the entire ABP1 gene along with 5’ non-coding region 
constituted the third clone. Abp1p seemed like the likeliest candidate for suppression 
of this allele but it remained to be confirmed. So I cloned the ABP1 gene, together 
with its presumed promoter region (~1000 base pairs 5’ of the start codon) into the 
pRS426 vector (see Chapter II for details). This construct was transformed into 
sla2CC strain and the rescued phenotype was studied in greater detail. 
5.3.1 High concentration of ABP1 can suppress the growth 
defects of the sla2CC mutant 
Full length Abp1p cloned into pRS426 vector, under the control of its own promoter 
was transformed into wild-type (W303) and sla2CC cells and tested for growth 
under high temperature. Drop-test was performed in which all the test strains were 
grown overnight to OD600 of 0.5 and then serial dilutions of the order 10X, 100X and 
1000X were performed. 10μl of each concentration of each strain was then dropped 
on a SD-agar plate lacking uracil. As a negative control, pRS426 without an insert 
was transformed into sla2CC and W303 cells. The result (Figure 5.1A) clearly 
shows that ABP1-pRS426 clearly affords a growth advantage to sla2CC at 37oC. I 
did not observe any deleterious effect of high-copy ABP1 in the wild-type strain. 
5.3.2 High concentration of ABP1 can rescue actin defects of 
the sla2CC mutant 
In order to understand how Abp1p is able to rescue sla2CC mutant, I was keen to 
study the various actin defects of sla2CC and whether Abp1p suppressed the 
phenotype. Cells of sla2CC genotype have drastic actin defects such as actin 
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clumps, mislocalized actin patches in mother cell as well as large cable-like actin 
structures. Test strains were cultured overnight and shifted up to 37
o
C for 3 hours, 
then fixed and stained with rhodamine-phalloidin. The cells were visualized under 
Zeiss epifluorescence microscope using TRITC filter and the actin structures were 
studied closely. In sla2CC the actin clumps were present as described in Chapter 4 
(Figure 5.1B, panel 1) and were present in more than 80% of cells observed. 
However, in sla2CC::ABP1-pRS426 cells, the clumps were present in less than 20% 
of the cells. The patches are smaller and better defined and more or less restricted to 
daughter cells in small to medium budded cells (Figure 5.1B, panel 2). However, 
W303 wild-type cells when over-expressing Abp1p had some of the actin patches 
misorganized to mother cells. Abp1p over-expressed under galactose inducible 
promoter is known be toxic to cells (Quintero-Monzon et al, 2005). Overexpression 
using 2μ vectoris of a lesser magnitude compared to GAL1 promoter-induced 
overexpression. Hence I did not observe any lethality in wild-type cells as reported 
because the dose may not have been sufficient to kill the cells. However in wild-type 
cells, an increase in concentration of Abp1p did cause some depolarization of cortical 
actin. Contrastingly, ABP1-pRS426 rescued the aberrant actin phenotype of sla2CC 
cells, and did not cause any additional actin disorders.  
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5.2.3 High concentration of ABP1 can rescue endocytic 
defects of the sla2CC mutant 
Actin defects of the sla2CC mutant resulted in a severe block in both fluid-phase as 
well as receptor-mediated endocytosis. I was very interested in finding out whether a 
high concentration of Abp1p was able to rescue the block in endocytosis in concert 
with the suppression of the actin phenotype. Cells were grown overnight to OD600 of 
0.5, refreshed for an hour or so at 25
o
C and then shifted up to 37
o
C for 2 hours. After 
which, 10μl LY yellow stock (4mg/ml) was added to the culture as described in 
Chapter 2 and the internalization reaction was carried out at 37
o
C for another hour. 
Visualization of the cells under the GFP filter allowed the tracking of dye from the 
extra-cellular matrix to the vacuole inside the cell. In W303 cells without Abp1p 
over-expression, almost 100% of the cells showed a clear vacuolar staining after 1 
hour with very little membrane staining while the sla2CC cells showed almost no 
vacuolar staining. The sla2CC::ABP1-pRS426 showed a marked improvement in its 
ability to uptake LY at 37
o
C. More than 70% of the cells showed LY accumulated in 
the vacuole. On the other hand, over-expression of Abp1p did not adversely affect the 
rate of LY uptake in W303 cells.  
 Next, I examined the internalization of Fur4p in order to track receptor-
mediated endocytosis. Cells were grown overnight at 25
o
C and then refreshed to 
OD600 ~0.5 for about an hour at 25
o
C. 20ml cultures were shifted up for 1hour prior 
to start of experiment. Cycloheximide (CHX) was added to a final concentration of 
1μg/ml, in order to halt protein synthesis (protocol described in detail in Chapter II). 
As described in Chapter IV, sla2CC cells show defective uptake of the receptor at 
higher temperature (only ~20% of Fur4p is cleared from the cell membrane after 80 
minutes) while in cells expressing wild-type Sla2p, nearly 80% of the receptors are 
cleared from the surface at the same time span. ABP1-pRS426 transformed into 
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sla2CC strain alleviated the defect (more that 50% of the receptors were cleared 
from the cell surface at the given time-frame) but it did not restore receptor-mediated 
endocytosis to wild-type levels. In wild-type cells, overexpression of Abp1p resulted 
in a slight decrease in the rate of receptor internalization – about 30% of Fur4p 
remained on the cell surface after 80 minutes, which is about 10% more than in wild-
type cells expressing the empty pRS426 vector. However, this decrease is not 
significantly large.  
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5.3.4 Physical interaction between Sla2p and Abp1p 
A genetic link between the two proteins has been established as the SLA2 gene 
was discovered in a screen for deletion mutants that were synthetically lethal with the 
abp1. However, a physical link between Sla2p and Abp1p was hitherto unreported. I 
was interested in finding out whether these two proteins interact directly in vivo. 
Using C-terminal HA and Myc tagged Abp1p and Sla2p respectively, I performed 
immuno-precipitation assay with wild-type levels of both proteins. Unfortunately no 
detectable interactions were observed (data not shown). Using the Abp1p-HA-
pRS426 construct transformed Sla2CCp-Myc-pRS314::sla2  and Sla2p-Myc-
pRS314::sla2 strains, I tried detect co-immunoprecipitation between the tagged 
proteins. A very weak interaction could be observed (Figure 5.2C lanes 7 and 8). I 
then tried to show the direct interaction between Sla2p and Abp1p using the yeast-
2hybrid system but was unable to detect -galactosidase activity beyond basal levels 
(data not shown). This led me to conclude that Sla2p and Abp1p, although present in 
the same endocytic coat complex, may come in close proximity to each other during 





















5.4.1 Over-expression suppression screen 
The suppression screening revealed possible novel function of Sla2p in other 
pathways like ER-Golgi transport and nuclear activity. SLA2 showed genetic 
interactions with various components of the ER-Golgi transport machinery such as 
GYP5 (GAP protein for Rab family members involved in ER-Golgi transport), BFR2 
(protein essential for survival upon BFA treatment, thought to function in secretion), 
LHS1 (molecular chaperone found in ER lumen) etc. ER-Golgi trafficking and 
secretion pathways have never been linked to Sla2p before. However, its mammalian 
counterparts HIP1 and HIP1r are implicated in Golgi transport. Knock down of 
HIP1R using siRNA caused a block in trans-Golgi network trafficking. The TGN 
appeared 5X larger due to accumulation of clathrin coated buds and vesicles. 
Moreover, the HIP1R protein was found to co-localize with well-known TGN 
markers (Carreno et al, 2004). It is possible that Sla2p play a minor role in this 
trafficking pathway as well. It would be interesting to perform co-localization studies 
with common Golgi, ER and TGN markers using TIRF or confocal microscopy to 
determine whether Sla2p indeed localizes to these organelles.   
 Endocytic proteins have recently shown to play important roles in the nucleus. 
Scd5p has been shown to shuttle between the cytosol and nucleus, although the two 
functions seem to be unrelated (Chang et al, 2006). Pan1p too has been shown to 
reside in the nucleus under certain conditions (this lab, unpublished data). In 
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mammalian cells, many endocytic proteins have well-established nuclear function. 
HIP1 associates with the androgen receptor (AR) at the plasma membrane and 
translocates to nucleus along with the hormone-bound receptor (Mills et al, 2005). In 
the nucleus, it binds to androgen responsive elements (ARE) found in the UTR of 
genes whose transcription is activated by AR. HIP1 was found to modulate 
transcription activity in vitro. Sla2p was found to have genetic interaction with Arp5, 
an actin related protein involved in chromatin remodelling. Actin itself has been 
found in the nucleus and implicated in the processed of transcription, RNA processing 
and export. It would open up an interesting chapter in the function of Sla2p, if its role 
in the nucleus can be established. 
5.4.2 ABP1 is an extragenic high-copy suppressor of the 
sla2CC mutant 
In this chapter I have shown that Abp1p overexpression can suppress the aberrant 
phenotypes of sla2CC strain. Sla2p was originally identified as a gene whose 
deletion caused synthetic lethality along with the ABP1 null mutant. Sla2p and Abp1p 
belong to the endocytic coat complex that includes other proteins such as Sla1p, 
Pan1p, clathrin and Scd5p. A direct interaction between Sla2p and Abp1p has never 
been reported. I was able to detect Abp1p signal in an immuno-precipitate of Sla2p. 
However, no interaction was observed in other assays such as yeast-2hybrid and GST 
pulldown. Since the latter two protocols usually detect direct interaction only, I safely 
can conclude that either the interaction between Sla2p and Abp1p is indirect or 
extremely transient. Since the two protein co-localize to the same sub-structure in the 
cortex and form inter-connections with other proteins in of the endocytic machinery, 
it is not difficult to imagine that their association might be via some other point of 
contact. Also, Sla2p and Abp1p co-localized for about 10 seconds or so, at the cortical 
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patch. This could signify that the association between the two is transient and perhaps 
only lasts for the duration that both these proteins remain at the surface.  
 However, despite no direct interaction between the two proteins, a strong 
genetic suppression was observed. The sla2CC strain is a novel temperature 
sensitive allele characterized in this study. The ablation of just 30 amino acids of 
Sla2p caused the cell to die at 37
o
C and caused profound actin and endocytic defects, 
at both permissive and non-permissive temperatures. I had hypothesized in Chapter 
IV that the defects in the strain could be due to, in part, the uncontrolled association 
of Sla2p’s THATCH domain with actin filaments that could lead to excessive 
stabilization of these filaments.  
 Abp1p itself is an actin-filament binding protein, which is thought to bind 
existing actin cables, via the ADFH domain and cause branching of the actin network. 
This function is especially important in endocytosis when this branching causes 
membrane curvature and also during vesicle internalization (Kaksonen et al, 2004; 
Winder et al, 2005 etc).  Abp1p could potentially compete with the unfettered 
THATCH domain of Sla2CCp, which is lacking the upstream helical domain (USH) 
and therefore not able to regulate its association with F-actin.  
 Overexpression of Abp1p has been reported to cause actin disorganization 
(Drubin et al, 1988 and Quintaro-Monzon et al, 2005). When I expressed Abp1p from 
a multi-copy plasmid with a 2μ replication site, I did observe mild actin defects in 
some cells but it was not as severe as what was reported by Drubin et al in their paper 
in 1988. The overexpression by the authors was ~5 fold in the protein level. I was 
able to replicate the actin defects reported by Quintaro-Monzon et al, (2005) when I 
similarly overexpressed Abp1p from a GAL1 inducible promoter (data not shown) in 
wild-type W303 cells. My conclusion remains that the W303 cells are more resistant 
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to slight perturbation of Abp1p concentration compared to the background used by 
Drubin et al in 1998. However, a massive overdose of Abp1p, via the GAL1 
promoter, indeed resulted in the whole actin cytoskeleton to be defective. 
 
5.5 FUTURE WORK AND PERSPECTIVES 
This study opens up a whole new avenue with respect to Sla2p function. It would be 
of great interest to find out the link between Sla2p and chromatin remodelling, as 
some of the genes involved in this pathway are able to rescue the temperature 
sensitivity of sla2CC mutant.  
 While a lot is known about Sla2p’s function in trafficking at the plasma 
membrane, very little is known about its role in the ER, Golgi or TGN. Protein 
secretion defects had been demonstrated in the sla2 strain, which tend to accumulate 
secretory vesicles. A closer look at the function of this protein in this pathway by 
studying genetic and protein-protein interactions, with the candidates isolated from 
my screen, would be most informative. 
 Thirdly, to prove my hypothesis as to whether or not Abp1p modulates Sla2p 
THATCH domain from excessively associating with actin filaments, several 
experiments can be designed. In vitro Sla2p-F-actin binding assays in the presence of 
high concentration of Abp1p could be performed to see if this hypothesis is sound. 
Using electron microscopy to determine the ultrastructure of the abnormal actin 
phenotype along with co-labelling with Sla2CCp would help in determining the 
association between them. Building from my data, Sla2p’s function in the cell can be 
more completely determined 
 






In this thesis I have shown the importance of phosphorylation of Sla2p as well as the 
vital role its C-terminal plays, in the context of cell survival, endocytosis and actin 
regulation. 
 Firstly, I was able to show that Sla2p is a substrate of Prk1p, a kinase that has 
an important role in actin regulation. Phosphorylation on Sla2p had subtle, 
modulating effects. A phospho-mimetic version of Sla2p – the Sla2
EE
p mutant- 
caused a slight defect in receptor-mediated endocytosis but not bulk internalization. 
On a gross level, phosphorylation did not affect localization, actin distribution or cell 
survival. However, when I looked deeper using very sensitive time-lapse microscopy, 
I detected a change in dynamics of Sla2p, which was dependant on its 
phosphorylation status. Sla2
EE
p had a much longer lifespan at the cortex, persisting 
for about 9 seconds more than wild-type protein or the non-phosphorylable Sla2
AA
p. 
Not only did phosphorylation of Sla2p affect its own dynamics, it also increased 
lifespan of Abp1p, Sla1p and Pan1p significantly. Pan1p was most drastically 
affected- it remained at the cortex nearly 10 seconds more than the wild-type protein. 
In order to rationalize this delay, I looked at protein-protein interactions between 
Sla2p and its binding partners. I found that Sla2p’s affinity for Scd5p decreased 
dramatically upon phosphorylation. In stark contrast, Sla2
EE
p had a greater affinity for 
Pan1p compared to Sla2
AA
p and Sla2p. This gives us an idea that phosphorylation 
modulates the activity of the protein subtly and changes it behaviour with its 
interacting partners as well.   
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 I proposed a model in which the differing affinities of Pan1p following 
Sla2p’s phosphorylation or dephosphorylation may play a role in modulating the actin 
polymerization function of Pan1p. In this model, the stronger affinity of Pan1p for the 
phosphorylated Sla2p acts as a negative feedback loop, ensuring that Pan1p remains 
phosphorylated, Sla2p-bound and therefore inactive. Both Pan1p and Sla2p are 
natively found in the phosphorylated form (Toshima et al, 2005, Zeng et al, 2007 and 
this study) and it is not unreasonable to assume that both these proteins are 
phosphorylated in a similar time frame- corresponding to the recruitment of Ark1p or 
Prk1p kinase at the cell cortex (Zeng et al, 2007, Jin and Cai, 2008, this study). This 
negative feedback ensures that there is no actin polymerization at the recruitment-
phase of endocytosis. Conversely, Scd5p has very weak affinity for phosphorylated 
Sla2p further ensuring that no Glc7p-mediated dephosphorylation occurs at that point. 
Subsequently binding of Scd5p to Sla2p will slowly bring about 
dephosphorylation that would serve to strengthen interaction between Scd5p and 
Sla2p and at the same time, weaken the bonds between Pan1p and Sla2p. Proximity to 
Scd5p to Pan1p via Sla2p could serve as a second entry point for Glc7p to access and 
dephosphorylate Pan1p. End3p was proposed to fulfill a similar function (Zeng et al, 
2007). 
 In Chapter IV I showed that the C-terminal region of Sla2p is vital for its 
function. Using various systematic deletions of the Sla2p C-terminal I determined the 
functions of the various domain. I also found that the coiled coil domain present from 
amino acid 700-730 is vital for Sla2p’s function. Deletion of this domain caused a 
severe defect of growth at 37
o
C, accompanied by severe actin aberration and 
endocytosis. Deletion of the entire C-terminal domain 700
th
 amino acid onwards, was 
less severe but still some endocytic as well as actin defects were seen. In contrast, 
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keeping the second coiled-coil domain and deleting amino acids 730 onwards 
behaved similar to the wild-type cell. This clearly points to the fact that the second 
coil has an important regulatory function.  
Two proteins, Ark1p and Scd5p were known to bind to the C-terminal of 
Sla2p. I investigated these interactions more closely and discovered that the second 
coiled-coil domain is necessary for binding of both these proteins to Sla2p. The C-
terminal trunction starting from the 700
th
 amino acid was not able to bind Ark1p or 
Scd5p, but keeping the coiled-coil domain restored interaction with both.  
 The deleterious effects of the sla2CC mutant could not be explained by its 
decreased affinity to Scd5p and Ark1p. I sought to explain this phenomenon by 
looking to the structure of the THATCH domain, which is preceded by the second 
coiled-coil domain. It had been reported that helical domain, just upstream of the 
I/LWEQ motif is important in inhibiting the actin binding ability of the THATCH 
domain. I propose the model that deletion of the second coiled-coil domain removes 
the USH and hence relieves the inhibition of the THATCH domain. This results in the 
C-terminal region of Sla2p binding and stabilizing actin filaments that leads to a block 
in endocytosis and appearance of actin clumps.  
 Thirdly in chapter V, I showed that several proteins in various pathways can 
alleviate the temperature sensitivity of the sla2CC mutant. The gene from this 
screen, which I went on to study in detail, was the ABP1 gene. High copy ABP1 could 
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